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List of abbreviation 
 
2,2-DMP = 2,2-dimehtoxypropane 
Ac2O = acetic anhydride 
CTP = cytidine triphosphate 
DCM = dichloromethane 
DMAP = 4-dimethylamino pyridine 
DMAPP = dimethylallyl pyrophosphate 
DXP = 1-deoxy-D-xylulose 5-phosphate 
EBC-46 = Tigilanol tiglate 
EDC = 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EtOAc = ethyl acetate 
EtOH = ethanol 
HRMS = High Resolution Mass 
IL = interleukin 
IPP = isopentenyl pyrophosphate 
MeOH = methanol 
MEP = 2-C-methyl-D-erythritol 4-phosphate  
MS-MS = Mass-Mass spectrometry 
MVA = mevalonic acid 
NMR = nuclear magnetic resonance 
Pe = petroleum ether 
PKC = protein kinase C 
PMA = see TPA 
PPTSA = pyridinium-p-toluensulphonic acid 
Py = pyridine  
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QToFMS = Time-of-flight mass spectroscopy 
RTX = resiniferatoxin 
SAR = structure-activity relationship 
t-BuOOH = tert-butylhydroperoxyde 
THF = tetrahydrofurane 
TPA = 12-O-tetradecanoyl phorbol-13-acetate 
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Scenario background 
 
It is not hard to believe that, even from the birth of modern science, chemists have turned their 
attention to traditional herbal medicine to discover drugs for the treatment of several diseases. 
The list of natural compounds isolated from medicinal plants has increased dramatically with 
the progression of analytics techniques, chromatographic methods, and spectroscopy. After 
almost two centuries of studies, interest for natural products in drug discovery programs has 
substantially dwindled in the last 40 years. Possible causes are the intrinsic difficulty of natural 
product purification from complex matrixes, the establishment of a supply chain, regulatory 
burdens and the attrition due to the re-discovery of known compounds. [1] According to 
Pharma R&D Annual Review 2019, biotechnological drugs are gaining ground thanks to a 
better-targeted therapy compared to small-molecules, that, nevertheless, still represent the 
largest class of current drugs. In this scenario, plants products are at position 11th, stable 
compared to 2018. Thus, natural products can still be of interest for drug discovery. [2, Table 
1] 
Origin N. of active products 2019 (2018) Trend 
Plant 266 (248) ↑ 
Bacterial 43 (51) ↓ 
Animal 35 (30) ↑ 
Fungal 27 (28) ↔ 
Other 24 (-) ↑ 
 
In this context, phorboids hold a special place. These polycyclic diterpenoids, typical of plants 
from the Euphorbiaceae and Thymelaceae have unique chemistry and biological activity. 
Thus, certain phorbol esters, a class of tigliane-type phorboids, act as ultra-potent analogues 
of 2,3-diacylglycerol (DAG) on Protein Kinase C (PKC), a series of serine-threonine kinases 
involved in several cellular pathways and related to carcinogenesis.  
Table 1. Pharma R&D Annual Review 2019 on drugs origin 
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12-O-tetradecanoylphorbol-13-acetate (TPA, PMA, 1) is extensively used in biomedical 
research, while resiniferatoxin (2), a daphnane-type phorboid is under development as an 
alternative to surgical denervation for intractable pain, ingenol mebutate (3), an ingenane-type 
phorboid is used for the treatment of actinic keratosis, and tigilanol tiglate (4), is under clinical 
development for the intratumor treatment of cancers. 
Despite their extensive use in biomedical research, and their potent and unique biological 
profile, phorboids are still largely unexplored in terms of chemistry, biosynthetic origin, and 
mechanisms of activity. This thesis aims at providing a contribution en route to the clarification 
of these issues. 
Part Ia describes an expeditious isolation method of the parent diterpene polyol phorbol from 
croton oil (Croton tiglium L. oil), and of the basic diterpenoid skeleton of tigilanol tiglate from 
left-overs from the isolation of this compound from the seeds of Fontainea picrosperma 
C.T.White.  
Part 1b presents SAR studies aimed at the exploration of the chemical space of tiglianes, and 
an exploration of their chemical reactivity. 
Part II presents a biosynthetic investigation on the origin of the tigliane skeleton, inspired by 
the Jakupovic proposal of non-lathyrane derivation of these compounds. The synthesis of 
labelled precursors is presented as well as a series of feeding experiments on Fontainea 
picrosperma. 
 
 
Fig. 1 TPA (1), Resiniferatoxin (2), Ingenol mebutate (3), Tigilanol tiglate (4)  
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1. Introduction 
 
Tiglianes are a class of diterpenoids, densely functionalized, that shares a 5/7/6/3 
hydrocarbon skeleton (1). Among all the polycyclic C-20 isoprenoids isolated from 
Euphorbiaceae and Thymelaceae and named phorboids, tiglianes represent the major class 
in terms of substitutions and variety of the diterpene core. The isolation of the parent alcohol 
was reported in 1934 by Flaschenträger during the investigation of the vesicant properties of 
Croton tiglium L. seeds oil [1]. The compound was named phorbol (2) after the name of the 
plant family (Euphorbiaceae) to which Croton tiglium belongs. Speculations and hypothesis 
regarding the structure of phorbol lingered for years papers in the chemical literature, backed 
up by degradative studies, [2] but only in 1967 Crombie finally elucidated its structure with a 
crystallographic study on a chloroform solvate of phorbol 20-(5-bromofuroate) registered at – 
160 °C [3].   
The noxious properties of the oil documented in folk medicine turned up the interest of several 
researchers that, towards the end of nineteenth century, began the investigation on the active 
fractions of the oil. Dunstan and Boole isolated an ethanol-soluble resinous mass, called 
Croton resin, which retained the irritancy of Croton oil and belying the hypothesis of Buchheim 
that the biological activity was related to a compound named Crotonoleic acid (subsequently 
revealed a mixture of fatty acids). [4] In 1941 Beremblum highlighted the co-carcinogenic 
properties of Croton oil, testing on mouse skin a subthreshold amount of oil with benzopyrone. 
[5] Only in 1968 with the isolation of 12-O-tetradecanoyl phorbol-13-acetate (TPA, PMA, 3) by 
Hecker (Fig. 2) and co-workers, the first pure tumor-promoting agent was characterized and, 
quite soon, was intended to be one of the most important agents in biomedical research. [6] 
TPA and other phorbol esters induce activation of PKC, a class of serine-threonine kinase, 
involved in a host of cellular activities. Mimicking the effect of diacylglycerol (DAG), PKC 
natural ligand, they can trigger a phosphorylation cascade resulting in a complex network like 
regulation of proliferation, apoptosis, cytoskeletal structure-function and histamine, IL-2 and 
cytokines releasing. [7]  
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Fig.1.1 Tigliane skeleton (1) Phorbol (2) TPA (3) EBC-46 (4) 
The ability to promote phenotypic changes in differentiation and/or apoptosis in cell lines and 
primary malignancies, prompted the use of TPA (PD-616) in clinical trial for treatment of Acute 
Myelogenous Leukemia or Myelodysplastic Syndrome [8] and Hematological malignancies. 
The first study was terminated for difficulties in patient enrollment while the second confirmed 
the feasibility of administrate TPA to humans. Despite this achievement, the study was not 
continued and the attraction towards phorbol esters shaded among the last years of XX 
century. [9] The interest for phorbol esters was rekindled in 2005 when the Australian 
company Ecobiotics discovered EBC-46 (Tigilanol tiglate, 4) from an endemic species 
belonging to Queensland rainforest, Fontainea picrosperma C.T. White. The company was 
driven by a unique approach that involves collecting information about distribution, habitats 
and ecological interactions of plants, animals and microbes of Australia’s tropical rainforest, 
named EcoLogic™. [10]  
PKCs, as well, are back to fashion due to recent considerations about the loss of function and, 
in some cases, complete inactivation of PKC isozymes mutations in human cancer cells. 
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Restoring the activity of the enzymes themselves by genome-editing revealed that PKCs work 
as tumor suppressor agent and, despite the unambiguous tumor promoting activity of phorbol 
esters, therapies should focus their attention in restoring their activity instead of inhibiting it. 
[11] 
1.1 Isolation 
 1.1.1 Croton tiglium L.  
 
Croton tiglium L. is a leafy endemic shrub native to Malabar, Ceylon, Amboina (of the Molucca 
islands), Philippines, Java and China belonging to the family of Euphorbiaceae. The fruits, 
ripped after 5 months from blossoming, are a three-celled capsule, each one contains a single 
seed. [12] The oil obtained from solvent extraction or cold squeezing can reach 30-45 %wt on 
seeds and 50-60%wt on the kernel. [13] Croton oil occurs in several folk medicines among 
South-East Asian country and even in some Africans: for example, in Malaysia the oil is used 
as purgative, for cancerous sores, carbuncle, colds, fever, paralysis; in Ghana, the seeds 
were used as fish poisoning while in Sudan as purgative again. [14] Describing medicinal 
plants of Ceylon, Joannes Scott referred to Jayapāla (Croton tiglium seeds) as the most potent 
purgative and leaves, acrid as well, source of burning sensation through mouth and throat. 
[12] 
The oil was imported by Dutch during the 16th century and in the following centuries lived a 
fluctuating interest by Europeans. During World War II, Croton oil was used as a denaturing 
agent for fuel alcohol to power torpedoes motors. USA Navy needed to render the alcohol 
undrinkable to prevent sailors from its consuming and, consequentially, intoxication and 
hangover. Sailors developed later a method to distil alcohol from the denatured one producing 
what was later called Gilly. [15] In the early winter of 1940, the Nazi party of Vidkum Quisling, 
after taking over of Norway, started to drain the provisions of the country to support German 
headquarters among Europe. Norwegian partisans, in response, ordered a large shipment of 
Croton oil from British officials to tamper with it a batch of sardines destined to Saint-Nazaire 
(a U-boat base with the duty to sink Allied ships bringing supply to England). [16] 
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Nowadays, Croton oil is used in biomedical research for assays like mice ears oedema test 
as a pro-inflammatory agent. [17] In homoeopathy, Tiglium officinale is used in the form of 
solution or granules in several dilutions (5 CH to 1000 CH) as a remedy for several diseases 
many of which related to the effect promoted by consumption of the oil itself. An interesting 
application of the oil was developed in cosmetic surgery as part of a recipe for deep chemical 
peeling; croton oil (from 0.1 % to 0.8 %, previously max concentration 2.1 %) is combined with 
USP phenol 88 %, water and Septisol, commercial name of hexachlorophene, an 
organochlorine disinfectant. After applying the mixture, the acid coagulates and precipitates 
skin proteins producing a frost effect (the way how varying degrees of white occur). Several 
months later, the skin appears translucent and with a significant wrinkles’ reduction. [18] 
Together with C. megalocarpus oil, C. tiglium oil was taken in consideration into biodiesel 
production in perspective to overcome petroleum-based diesel. This specific application 
influenced the cultivation of the plant in China, where domestication and clone selection were 
performed to achieve high yields in oil production. [19] 
 
  
Fig. 1.2 Croton tiglium drupes (left) and Croton oil (right) 
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1.1.1.1 Naturally occurring tiglianes in Croton tiglium L. 
 
The distribution of tigliane-phorboids in Croton oil was under investigation since the first half 
of the XX century but, still now, new phorboids are elucidated from seeds, leaves or the oil 
itself of Croton tiglium. Phorbol-like diterpenoids are the most abundant secondary 
metabolites isolated in the oil.  
The tetracyclic system (5/7/6/3) is based on a trans-bridgehead bicyclo [4.4.1] undecane core. 
Traditionally, bi-dimensional representation of the molecules provides for writing the 
cyclopentenone ring A on the right side with a trans-bridge at C-4 and C-10. Most phorboids 
retain a hydroxy group at C-4 in β-position or, lower percentage, a complete lack of 
functionalization with an inversion of the configuration (4α-4-deoxy phorbol esters). Ring B is 
characterized by an allyl alcohol function nestled into the cycloheptane ring; the (Z)-oriented 
olefin side is included between C-6 and C-7 with the methylene group merging out of the plane 
from C-6. A trans-bridge binds again ring B and C through C-8 and C-9, which possess a 
tertiary β-hydroxy group. On cyclohexane ring C, it is possible to find the anti-oriented glycol 
function at positions C-12 and C-13, usually esterified and involved in mimicking the acyl 
chains of DAG in biological systems. Ring D is directly linked to ring C through C-13 and C-
14, and it is characterized by a cis-oriented β-cyclopropane ring with two methyl group 
attached at the methylene bridge. The 1H- and 13C-NMR features of phorbol (2) are 
Fig. 1.3 1H- and 13C-NMR data of phorbol (2): (MeOD-d4, 400 MHz and 101 MHz, 
respectively). J values: δ 7.63 = 2.4,1.4 Hz; 5.62 = 6.0, 2.1 Hz; 4.07 = 10.2 Hz; 3.18 = 
5.8 Hz; 3.11 = 2.8 Hz; 2.50 = 19.1 Hz; 1.96 = 10.1, 6.5 Hz; 1.77 = 3.0, 1.4 Hz. 
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summarized in Fig. 3. Some of the most prominent aspects of the NMR spectra are the 
diastereotopy of protons at C-5 and C-20 whenever the parent alcohol is esterified. Both the 
AB systems retain a wide J coupling (from 18.0 to 10.0 Hz). The electron-withdrawing effect 
of the enone in ring A reduces the electron density at β-position resulting in a downfield shift 
of C-1 at δ 7.6 ppm (deshielded). Notably, the cyclopropane proton of C-14, typically the most 
upfield doublet of the spectra, is around δ 0.90 with a J value included between 5.0-6.0 Hz; 
esterifications at C-12 and C-13 result in an α and γ-downfield and β-upfield shifts. [20] 
Some of the esters that have been detected so far in Croton oil are presented in the following 
table:  
Compounds R1 R2 R3 
Phorbol (2) H H H 
Phorbol-12-myristate H Ac H 
Phorbol-12-monoacetate H Ac H 
Phorbol-12,13-diacetate H Ac Ac 
Phorbol 12-acetate-13-tiglate H Ac Tigl 
Phorbol 12-acetate-13-decanoate H Ac Capr 
Phorbol 12-acetate-13-dodecanoate H Ac Laur 
Phorbol 12-tiglate-13-acetate H Tigl Ac 
Phorbol 12-decanoate-13-acetate H Capr Ac 
Phorbol 12-dodecanoate-13-acetate H Laur Ac 
Phorbol 12-tetradecanoate-13-acetate (3,TPA,PMA) H Myr Ac 
Phorbol 12-hexadecanoate-13-acetate H Palm Ac 
Phorbol 12,13-dibutyrate H But But 
Phorbol 12-butyrate-13-dodecanoate H But Laur 
Phorbol 12-tiglate-13-propionate H Tigl Prop 
Phorbol 12-tiglate-13-isobutyrate H Tigl iBut 
Phorbol 12-tiglate-13-butyrate H Tigl But 
Phorbol 12-tiglate-13-(S)-2-methylbutyrate (5) H Tigl αMeBu 
Phorbol 12-tiglate13-octanoate H Tigl Capryl 
Phorbol 12-tiglate-13-decanoate H Tigl Capr 
Phorbol 12-tiglate-13-dodecanoate H Tigl Laur 
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Phorbol 12-((S)-2-methylbutyrate)-13-isobutyrate H αMeBu iBut 
Phorbol 12-((S)-2-methylbutyrate)-13-tiglate H αMeBu Tigl 
Phorbol 12-((S)-2-methylbutyrate)-13-octanoate H αMeBu Capryl 
Phorbol 12-((S)-2-methylbutyrate)-13-decanoate H αMeBu Capr 
Phorbol 12-((S)-2-methylbutyrate)-13-dodecanoate H αMeBu Laur 
Phorbol 12,13-dibenzoate H Benz Benz 
Phorbol 12-decanoate-13-((S)-2-methylbutyrate) H Capr αMeBu 
Phorbol 12,13-didecanoate H Capr Capr 
Phorbol 13,20-diacetate Ac H Ac 
Phorbol 13-acetate-20-oleate Oleic H Ac 
Phorbol 13-acetate-20-linoleate Linoleic H Ac 
Phorbol 13-tiglate-20-linoleate Linoleic H Tigl 
Phorbol 12,13,20-triacetate (4) Ac Ac Ac 
Phorbol 12-tetradecanoate-13,20-diacetate Ac Myr Ac 
 
Table 1.1. Summary of tiglianes isolated from Croton tiglium L. 
 
Besides the canonical esters previously reported, other tiglianes from Croton tiglium were 
isolated with different functionalizations, for example, at ring B like in crotignoids A and B with 
a β-hydroperoxide at C-7 and a transposed double bond between C-5 and C-6. In crotignoids 
C and D, the peroxidic function is substituted by a β-hydroxy group while in crotignoids E, F 
and G a keto one occurs. The aldehydic analogue at C-20 was isolated as well from leaves 
keeping the same structural features of phorbol esters. [21] Rare tiglianes that show unusual 
 22 
 
rearrangement of cycle D is crotonol A, where a unique C-7/C-14 fused oxetane ring replaces 
the cyclopropane, and crotonol B that underwent to a ring expansion of ring C resulting in a 
5/7/7 system. [22] A further complication in the attempt to rationalize the biosynthetic pathway 
of tiglianes comes in 2016, where a class 4-deoxy-4β-phorbol esters have been isolated from 
a methanolic extract of the seeds. [23] 
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1.1.1.2 Research paper - An improved preparation of phorbol from Croton oil 
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1.1.2 Fontainea picrosperma C.T. White 
 
Fontainea picrosperma C.T. White is a sub-canopy tree endemic of the northeastern forests 
of Australia. The genus Fontainea consists of only nine species mostly distributed between 
eastern Australia, Papua New Guinea, New Caledonia and Vanuatu. [24] The fruits, succulent 
orange/red drupes, reach maturation between December and January and undergo to scatter-
hoarding by cassowaries, giant tailed rats and musky rat kangaroos. [25] 
During the collection of data for understanding the interactions between plants, animals and 
microbes of the Atherton Tablelands rainforests, the Australian pharmaceutical company, 
QBiotics Ltd., noticed that F. picrosperma fruits were or deprived of them fleshes (seed keeps 
untouched) or completely regurgitated by wild animals whenever the seeds were broken.  
The further analysis of the bioactive fraction from the kernel revealed a quite huge percentage 
of diterpenoids esters, structurally related to tigliane but with some analogy with daphnanes. 
A plethora of 5β-hydroxy-6,7α-epoxy phorbol esters were addressed to be the main 
compounds, implied in the offensiveness of the kernel and that justify the missed zoochory. 
Even if 5β-hydroxy-6,7α-phorbol esters are not an entirely new sub-group in tigliane type 
diterpenoid, none of the previous one isolated present a hydroxy (and its relative acyl 
decoration) at C-12. The oil obtained by solvent extraction (usually methanol) is closed to 10-
13 % from undried frozen kernel and, of this, up to 6 % are 5β-hydroxy-6,7α-phorbol esters. 
A complete phytochemical composition is not established yet due to privileged researches on 
the bioactive fractions and therefore to tiglianes diterpenoids.  
Fig. 1.6 Fontainea picrosperma C.T.White fruits’ detail. 
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1.1.2.1 Isolation of 5β-hydroxy-6,7α-epoxy-5,20-acetonide phorbol from 
F.picrosperma oil 
 
The strategy aimed to reduce the incredible variety of C-12,13 esters to only one molecular 
identity optimized in 1.2.1.2, was applied as first at the methanolic extract of F. picrosperma 
kernel but treatment with sodium methylate completely degraded all the epoxytiglianes.  
This observation was quite surprising because of the hydrolytic behavior with both TPA 
(tigliane ester) and mezerein (daphane ester), whose share structural elements with the 
epoxytiglianes (Fig. 7), give a precise conversion to the parent polyol (respectively, phorbol 
and 12-hydroxydaphetoxin). [2, 26]  
This Gestalt effect suggests that the chemistry of these compounds goes beyond the one 
expected from the sum of the isolated structural elements and a new approach has to be 
developed.  
In order to reduce possible base-induced rearrangement at ring B (Payne rearrangement, Fig. 
8), the secondary alcohol at C-5 and primary one at C-20 were protected in an acetonide 
using both acetone and 2,2-dimethoxypropane (ratio 2:1) as reagent in the presence of an 
excess of the mild acid pyridinium p-toluenesulfonate (PPTSA), to generate the protected 
ester with a satisfactory yield. The obtained acetonide resulted stable in basic conditions and 
transesterification can be achieved with Cs2CO3 in methanol, a surprisingly mild condition. 
Fig. 1.7 Structural homologies between TPA (3), a general 5β-hydroxy-6,7α-epoxy 
tiglianes and mezerein (10) 
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This protocol proved a convenient source of the key intermediate 11 to sustain structure-
activity studies and increase the yield of extraction of tigliane skeleton for further biosynthetic 
investigation (close to 8 % w/w on crude extract). 
 
 
Fig. 1.8 Payne rearrangement catalysed by base transesterification approach 
Fig. 1.9 Preparation of 5β-hydroxy-6,7α-epoxy-5,20-acetonide phorbol from 
F.picrosperma oil 
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1.2.2.2 Supporting information 
 
Chemicals were purchased from Alfa Aesar (Kandel, Germany), Fluorochem (Hadfield, UK) 
or Sigma Aldrich Chemie (Steinheim, Germany) and used without any further purification. 
Solvents were purified by distillation and dried according to standard methods. All non-
aqueous reactions were performed under an inert atmosphere (nitrogen) in flame-fired flasks. 
Thin-layer chromatography was performed with 0.2 mm precoated plastic sheets TLC silica 
gel 60 F254 (Merck) and visualized by UV inspection (254 nm) and stained with 5 % H2SO4 in 
methanol before heating. Column chromatography was carried out using Merck silica gel 60 
(70-230 mesh). 1H and 13C NMR spectra were recorded with Pollux Bruker AV III Prodigy (400 
MHz) spectrometer and referenced against solvent signals (1H-NMR residual proton signals: 
CDCl3 δ=7.26; 13C-NMR: CDCl3 δ=77.16). Starting material was supplied by INDENA s.p.a 
(Milano, Italy) for QBiotics Limited (Yungaburra, Australia) as side-cuts from GMP and non-
GMP production of EBC-46 (Tigilanol tiglate). 
Synthesis of 12,13-diacyl-6,7α-epoxyphorbols-5,20-acetonide (11): To a solution of F. 
picrosperma oil side cuts (10.0 g, IDT Silica 3A-4D EBC concentrate 13.03.2015) in acetone 
(54 mL) and 2,2-dimethoxypropane (27 mL), pyridinium-p-toluenesulfonate (2.7 g) was added 
at room temperature. After 4 days, the reaction was diluted with H2O and extracted EtOAc. 
The combined organic layers were dried over Na2SO4 and concentrated in vacuo to afford 
10.82 g of 11. TLC (petroleum ether/ethyl acetate 6:4): Rf= 0.67. 
Synthesis of 5β-hydroxy-6,7α-epoxy phorbol 5,20-acetonide (12): To a solution of 11 
(10.82 g) in MeOH (5 mL), a freshly prepared solution of Cs2CO3 in MeOH (20 mL, 0.3 M) 
was slowly added at room temperature. The color of the reaction changes from orange to dark 
brown. After 3 days, the reaction was diluted with H2O (2.8 mL to get a ratio MeOH:H2O 9:1) 
and extracted several times with petroleum ether. The aqueous phase was acidified with 
H2SO4 1 M to pH ≈ 3, dilute with brine and extracted with EtOAc. The combined organic layers 
were dried over Na2SO4. After evaporation, the residue was purified by gravity column 
chromatography on silica gel (pe/EtOAc 2:8) affording 12 (1.94 g) as yellowish amorphous 
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solid. Trituration with Et2O afforded an oat-meal colored powder (1.25 g). TLC (petroleum 
ether/ethyl acetate 6:4): Rf= 0.22. 1H NMR (400 MHz, MeOD-d4) δ 7.73 (dt, J = 2.8, 1.3 Hz, 
1H), 4.20 (d, J = 13.0 Hz, 1H), 4.13 (s, 1H), 4.10 (d, J = 9.9 Hz, 1H), 3.82 (p, J = 2.7 Hz, 1H), 
3.46 (d, J = 13.0 Hz, 1H), 3.15 (d, J = 7.1 Hz, 1H), 3.09 (s, 1H), 1.82 (dd, J = 2.9, 1.3 Hz, 3H), 
1.75 (dq, J = 9.7, 6.5 Hz, 1H), 1.52 (s, 3H), 1.46 (s, 3H), 1.37 (s, 3H), 1.23 (s, 3H), 1.06 (d, J 
= 6.5 Hz, 3H), 1.03 (d, J = 7.1 Hz, 1H).13C-NMR (101 MHz, MeOD-d4): δ = 208.05 (Cq), 162.77 
(CH), 135.21 (Cq), 102.24 (Cq), 82.53 (CH), 78.39 (Cq), 74.10 (Cq), 70.07 (CH), 66.61 (CH2), 
66.59 (CH), 63.40 (Cq), 62.74 (Cq), 52.66 (CH), 48.68 (CH), 37.83 (CH), 36.94 (CH), 27.75 
(CH3), 24.42 (CH3), 23.72 (CH3), 22.92 (CH3), 17.96 (CH3), 16.16 (CH3), 10.09 (CH3). 
 
  
Fig. 1.10 1H-NMR spectra of 12 
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Fig. 1.11 13C-NMR spectra of 12 
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1.2 Chemistry of tiglianes: SAR studies on phorbol esters 
 
The unique biological profile exploited by 5β-hydroxy-6,7α-epoxytiglianes compared to other 
phorbol esters was at the base of the challenging rationale aimed to design hybrid molecules 
between the two experimental drug candidate, TPA and EBC-46. The chemical space around 
the esters at C-12 and C-13 was explored in previous activities. It led to the conclusions that 
significant cytotoxicity is favored by α-branching whenever the two acyl groups are different 
and higher, or at least comparable, if the acylation profile consists in a symmetric pair of linear 
aliphatic acids having at least six carbons each. Thus, the seven-membered ring B was 
investigated in terms of the occurrence or lack of the natural substituents: β-hydroxy at C-5 
and 6,7-α epoxide. [Fig. 10] 
 
 
 
 
 
 
  
Fig. 1.12 Analogies and differences between EBC-46 (5) and TPA (8) 
 40 
 
1.2.1 Esterifications in phorbol  
 
The isolated parent alcohol phorbol (2) or 5β-hydroxy-6,7α-epoxy phorbol 5,20-acetonide (12) 
can be selectively esterified at position C-12, C-13 and C-20. The primary allylic alcohol at C-
20 is the most reactive and, in order to have access to the diol on ring C, must be protected. 
Traditionally, protection is carried by acylation, as an acetate, or with trimethylsilyl chloride to 
afford the 20-trityl ether. Other silyls protecting group have shown weak stability at C-20 and 
often are extruded during work-up. The protected derivative appears more stable than the 
parent alcohol suggesting the importance of shielding the allylic alcohol in case the product 
won’t be previously crystallized. Both the protecting group, by the way, can be easily removed 
by acid solvolysis in methanol. Once protected, phorbol-20 trityl ether or 20-acyl phorbol gives 
access at positions C-12 and C-13 that, for example, in Steglich conditions (N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide, EDC) and DMAP (4-dimethylaminopyridine) 
provides the mono- or di-esters. Although the expected product from mono-esterification 
would be the ester at C-12 (as secondary alcohol is most reactive than the tertiary at C-13), 
the isolated one is the 13-acyl ester.  
What is believed is that the activated acid is firstly esterified at C-12 and, subsequentially, the 
lone pair of electrons on the vicinal oxygen proceed via a nucleophilic attack at neighbour-
carbonyl to de-acylate it and re-esterify itself. This migration has essential consequences in 
Fig. 1.13 Esterification course in tiglianes. The anchimeric effect of C-12 to esterify C-13 
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the development of a synthesis of phorbol derivatives, as exemplified by the synthesis of 12-
tigloyl-13-(S)-methylbutyril phorbol, the analogue of the drug candidate EBC-46. (Fig. 1.11) 
Esterification of aliphatic acids or not particularly hindered ones take place under Steglich 
conditions with variable yields. However, as soon as a hindered substituent has to be used, 
the previous conditions do not produce any results. After several trials, it was observed a 
successful functionalization under Yamaguchi conditions with 2,4,6-trichlorobenzoyl chloride 
and diisopropylethylamine (DIPEA). 
The synthesis of 16 proceeds starting from phorbol (2), isolated as in paragraph 1.1.1.2, 
protected with trityl chloride at C-20. The first esterification was led under Steglich conditions 
with (S)-(+)-2-methylbutyric acid, EDC and a catalytic amount of DMAP. Conversely, 
esterification at C-13 was done with Yamaguchi reaction affording 15 but, during the work-up 
of the reaction, the slightly acidic condition induces removal of the protecting group. The 
residual protected derivate was deprotected with perchloric acid in MeOH to afford product 
16. (Fig. 1.12) 
Despite the accessible synthesis shown, preliminary bioactivity studies reveal an 
indiscriminate activation of PKC as canonical phorbol esters, suggesting that the selectively 
could arise from modification at ring B, like the 5β-hydroxy group or the 6,7α-epoxide. 
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.  
  
Fig. 1.14 Synthesis of EBC-46 analogue with phorbol 
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1.2.2 Allylic oxidation on ring B 
 
Oxidation is one of the most critical chemical transformations in natural products total 
synthesis both as for stabilization addition on a vicinal functional group and for simplify further 
modifications by the modification of the new framework. C-H oxidation of hydrocarbon is 
generally complicated and often require special conditions to achieve chemo-, regio- and 
stereoselectivity. [2] 
As first, we have decided to investigate oxidative conditions on 12,13-diacyl-20-trityl phorbol, 
aware of the intrinsic difficulty already described for ingenane diterpenoids. Protection of the 
primary alcohol is just as compulsory at C-20, in order to avoid oxidation to the corresponding 
aldehyde, as it is protection at C-12 and C-13. An α-ketol rearrangement was described by 
Hecker in 1969 to produce abeo-phorbols whenever PCC it is used as oxidizing agent. (Fig. 
1.13)  
Therefore, phorbol (2) was protected at C-20 with triphenylmethyl (Trityl) chloride (10) and 
esterified at C-12 and C-13 with Ac2O/Py to achieve 12,13-diacetyl-20-trityl phorbol (11). The 
intermediate 11 was used as starting material for allylic oxidation reactions like SeO2/t-BuOOH 
and Phenylselenynic anhydride, but none of the mentioned procedures led to the allylic 
alcohol. Interestingly, the reactions with selenium derivatives promoted the removal of the 
protecting group and the oxidation of the primary alcohol to the corresponding aldehyde.  
A change in the protecting group was then evaluated in terms of stability under the reported 
conditions, but the product isolated was the same. (Fig. 1.14) 
Fig. 1.15 α-ketol rearrangement PCC mediated on 12-dehydro-20-trityl phorbol 
 44 
 
 
Chromium (VI)-based allylic oxidations are used as well in natural products total synthesis. 
From CrO3 to more stable PCC and PDC, these reagents accomplish perfectly insertion of a 
keto group in hydrocarbon scaffold as accomplished by Nicolau and co-workers in 1994 in 
total synthesis of taxol [3]. Therefore, product 17 has been used in the conditions reported (30 
eq PCC, 20 eq NaOAc), but no significant product was obtained. By simple TLC analysis was 
evident the removal of the protecting group, followed by a decomposition of the starting 
material. The slight acidity of PCC that it is generally quenched by adding sodium acetate 
could have promoted the deprotection at C-20 inducing subsequentially a decomposition of 
the residue.  
Another trial was performed with Pd(OH)2 on carbon/t-BuOOH/K2CO3, but in this case, a 
complete lack of reactivity was observed.  
We hypothesize that the “cage-like” conformation could represent an obstacle to target ring B 
in phorbol, so we have thought to flatten the trans-bridged cyclic system to expose better the 
7-member ring by reduction of the enone system on ring A and protection of the diol C-3 and 
Fig. 1.16 Unexpected synthesis of 12,13-diacetyl-20-formyl phorbol 
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C-4 as an acetonide. The first step, after acylation of the reactive hydroxy groups, was a Luche 
reduction to achieve the β-hydroxy allylic alcohol on ring B. In fact, in order to reach proper 
protection of the 1,2-diol system a syn stereoisomerism would be preferred. The diol 20 was 
protected 2,2-dimethoxypropane:acetone (1:2 ratio) with pyridinium-p-toluenesulfonate in 
catalytical amount. (Fig. 1.15) 
Product 21 was used, as first, in the same condition of the expedited reaction tried on the 
triacetate wild-type. Reactions with selenium do not bring to any reactivity while, interestingly, 
PCC/NaOAc (Nicolau’s conditions) affords products from the oxidation at C-10. (Fig. 1.16)  
The oxidation of the C-10 allyl alcohol (Fig. 1.17, a) might induce a ring opening through the 
deprotonation at C-11, allowing the obtainment of an intermediate seco phorbol esters. The 
enol group at C-9 can rearrange allowing the elimination of an acetate to get 22a.  
Conversely, the activated alcohol as chromate ester (Fig. 1.17, b) can transforms the alkene 
into an epoxide fostering the attack on the more substituted carbon. The re-oxidation to the 
corresponding ketone at C-7 leads to 22b. [5] 
Fig. 1.17 Strategy to oxidize C-5 position in 12,13,20-triacetyl phorbol-3,4-acetonide 
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Fig. 1.19 Proposed mechanism for 22a and 22b  
Fig. 1.18 PCC/NaOAc allylic oxidation of 21 
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Possibly, flattening of the bicyclic ring exposes better the system to oxidative condition, paving 
the way for the discoveries of new reactions around the chemistry of tiglianes. Alternative 
oxidations will be taken in considerations to reach the desired goal. 
1.2.3 Deoxygenation on 5β-hydroxy-6,7α-epoxy phorbol 5,20-acetonide 
The second strategy among the synthesis of EBC-46 analogues intended to elucidate 
substructures that retain biological selectivity was deoxygenation of the epoxide. It is known 
that epoxidation of phorbol esters with peroxy acids (like m-chloroperbenzoic acid) produces 
selectively β-epoxide and that α-epoxidation, the natural one, can be achieved using 
vanadium-based reactions in the presence of chiral ligand. [6] 
In order to synthesize complementary molecules for our library, we decided to start from the 
isolated 5β-hydroxy-6,7α-epoxy phorbol 5,20-acetonide (12). As first, protection at position C-
12 and C-13 was achieved by acylation with hexanoic acid (23). Then, a series of reactions 
were attempted to produce the olefinic derivative. 
Based on previous laboratory experience on deoxigenative chemistry of triterpenoids, the 
reaction with iodine with triphenylphosphine was experienced as first. The reaction, at room 
temperature under inert atmosphere, produces selectively the iodohydrine derivative with 88 
% of yield. Interestingly, taking inspiration by Garlaschelli and Vidari upon the reduction of 
epoxide to alkenes, iodohydrine intermediate should be formed as first, and a subsequent E2-
iodo elimination with triphenylphosphine oxide formation should take place. [7] 
Fig. 1.20 Synthetical strategy to synthesize 12,13-dihexanoyl phorbol 5,20-acetonide 
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The reaction in dichloromethane, in a dry or wet atmosphere, produces only the iodohydrine 
5,20-acetonide derivative but, if it is performed in acetonitrile, beside the epoxide opening the 
cleavage of the acetonide is prompted by in situ formations of HI.  
Conditions Product 
TPP, I2  24: 12,13-dihexanoyl-6-hydroxy-7-iodo 
phorbol-5,20 acetonide (88 %) 
Zn, AcOH, AcONa, NaI (rt or ∆)  Not react 
SmI2 26: unknown structure 
Zn, CuSO4, 80 °C Not react 
Metrioxorhenium (VII), TPP Not react 
NaI, Me3SiCl Starting material decomposition 
TPP, I2, K2CO3 Not react 
CeCl3*7H2O, (EtO)3P (rt or ∆) Not react 
NaI, (EtO)3P Not react 
p-TSA*H2O, NaI 24, 25 
AcOH, NaI Not react 
(EtO)3P, microwave Not react 
n-BuLi, SnCl2, Me3Al (0°C to rt) Not react 
Noteworthy is the deoxygenation mediated by samarium iodide, which it is prepared in situ by 
reaction of samarium with 1,2-diiodoethane in dry THF (Kagan method). The latter was let it 
react with 23, and complete conversion of starting material was observed but the isolated 
product was not the expected olefin. A further rearrangement of phorbol occurred and the 
structure is still under investigation to establish the proper connectivity. 
Table 1.1 Attempted reaction to deoxygenate 5β-hydroxy-6,7α-epoxy phorbol 5,20-
acetonide 
Fig. 1.21 Synthetical strategy to synthesize 12,13-dihexanoyl phorbol 5,20-acetonide 
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Due to intrinsic difficulties to deoxygenate directly 23, a two-step strategy was then evaluated 
to reduce the iodohydrine derivative into the corresponding alkenes. Again, trying to access 
the tigliane skeleton represents an obstacle and the expedited conditions degrade, rearrange 
or cleavage the protecting group as shown in table 1.2.  
Conditions Product 
SnCl2, POCl3 Starting material decomposition 
Zn, EtOH, 80 °C 27: unknown structure 
Mesyl chloride, TEA Not react 
p-TSA, NaI 12,13-dihexanoyl-6-hydroxy-7-iodo phorbol 
In conclusion, the recent chemistry under developing aimed to synthesize a library of 
compounds with or without functional groups that naturally occurs in the experimental drug 
tigilanol tiglate (EBC-46) reveal an unexpected series of products never described so far in 
the chemistry of phorbol (tiglianes). Further efforts are required on the basis of all the 
strategies tried up to now. 
  
Table 1.2 Attempted reaction to reduce the iodohydrine 24 
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1.2.4 Supporting information 
 
Chemicals were purchased from Alfa Aesar (Kandel, Germany), Fluorochem (Hadfield, UK) 
or Sigma Aldrich Chemie (Steinheim, Germany) and used without any further purification. 
Solvents were purified by distillation and dried according to standard methods. All non-
aqueous reactions were performed under an inert atmosphere (nitrogen) in flame-fired flasks. 
Thin-layer chromatography was performed with 0.2 mm precoated plastic sheets TLC silica 
gel 60 F254 (Merck) and visualized by UV inspection (254 nm) and stained with 5 % H2SO4 in 
methanol before heating. Column chromatography was carried out using Merck silica gel 60 
(70-230 mesh). 1H and 13C NMR spectra were recorded with Pollux Bruker AV III Prodigy (400 
MHz) spectrometer and referenced against solvent signals (1H-NMR residual proton signals: 
CDCl3 δ=7.26; 13C-NMR: CDCl3 δ=77.16).  
Synthesis of 20-trityl phorbol (13): To a solution of phorbol (682.6 mg, 1.873 mol, 1 eq) in 
pyridine (7 mL), triphenylmethyl chloride (2.61 g, 9.365 mol, 5 eq) and DMAP were added at 
room temperature. After stirring it for 3 h, the reaction was diluted with H2SO4 1 M aq. sol and 
extracted three times with EtOAc. The combined organic layers were dried over Na2SO4. After 
evaporation, the residue was purified by gravity column chromatography on silica gel 
(pe/EtOAc 4:6) affording 13 (830 mg, 1.368 mol, 73 %) as white amorphous powder. TLC 
(EtOAc): Rf= 0.52.1H NMR (400 MHz, CDCl3) δ 7.6 (dd, J = 2.7, 1.4 Hz, 1H), 7.5-7.2 (m, 15 
H), 5.55 (d, J = 4.0 Hz, 1H), 4.14-4.10 (m, 1H), 3.59 (J =12.5 Hz, 2H), 3.04 (t, J = 5.1 Hz, 1H), 
2.92-2.87 (m, 1H), 2.45 (d, J= 20.5 Hz, 1H), 2.35 (d, J= 19.0 Hz, 1H), 2.12 (s, 1H), 1.86 (dq, 
J =11.0, 6.4 Hz, 1H), 1.79-1.76 (m, 3H), 1.32 (s, 3H), 1.19 (s, 3H), 1.07 (d, J= 6.5 Hz, 3H), 
0.80 (d, J= 5.1 Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3) δ 208.1, 159.8, 143.9, 139.0, 133.0, 
128.7, 128.5, 127.7, 126.7, 87.0, 81.5, 78.4, 73.6, 68.8, 62.5 , 57.6, 45.2, 39.5, 39.0, 36.2, 
26.8, 23.4, 17.4, 15.1, 10.3.  
Synthesis of 13-(S)-2-methylbutiryl-20-trityl phorbol (14): To a solution of (S)-(+)-2-
methylbutyric acid (107.6 µL, 0.989 mmol, 1.2 eq) in DCM (5 mL), EDC (189.6 mg, 0.989 
mmol, 1.2 eq) and DMAP were added at room temperature. When EDC was completely 
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dissolved, a solution of 13 (500 mg, 0.824 mmol, 1 eq) in DCM (10 mL) was added dropwise. 
After stirring it overnight, the reaction was diluted with brine and extracted three times with 
DCM. The combined organic layers were dried over Na2SO4. After evaporation, the residue 
was purified by gravity column chromatography on silica gel (pe/EtOAc 6:4) affording 14 
(278.9 mg, 0.403 mmol, 49 %) as pale-yellow amorphous powder. TLC (petroleum ether/ethyl 
acetate 7:3): Rf= 0.13. 1H NMR (300 MHz, CDCl3) δ 7.6 (s,1H), 7.5-7.35 (m, 6H), 7.32-7.20 
(m, 9 H), 5.56 (d, J = 4.0 Hz, 1H), 3.99 (d, J =10.3 Hz, 2H), 3.6 (s, 2 H), 3.22 (d, J = 16.3 Hz, 
1 H), 3.12 (m, 1 H), 3.10 (d, J = 2.7 Hz), 2.4 (d, J = 16.3 Hz), 2.5 (m, 1 H), 1.98 (s, 3 H), 1.75 
(s, 3 H), 1.5 (m, 2 H), 1.24 (s, 3H), 1.20 (s, 3H), 1.10 (s, 3 H), 0.98-0.87 (m, 7 H).13C NMR (75 
MHz, CDCl3) δ 194.46, 172.03, 144.85, 144.40, 141.57, 138.30, 128.92, 128.07, 127.77, 
126.4, 86.66, 79.36, 75.88, 74.63, 65.2, 64.72, 40.95, 42.8, 41.19, 40.6, 38.96, 26.86, 20.2, 
23.38, 25.1, 11.8, 16.36, 10.66, 10.32.  
Synthesis of 12-tigloyl-13-(S)-2-methylbutyril-20-trityl phorbol (15): To a solution of tiglic 
acid (289.8 mg, 2.895 mmol, 20 eq) and diisopropylethylamine (504.26 µL, 2.895 mmol, 20 
eq) in toluene (3 mL), 2,4,6-trichlorobenzoyl chloride (452.3 µL, 2.895 mmol, 20 eq) was 
added. After stirring it overnight, the reaction was filtered and the residue was evaporated in 
vacuo. The crude was re-dissolved in toluene and added dropwise to a pre-mixed solution of 
14 (100 mg, 0.148 mmol, 1 eq) and DMAP (17.7 mg, 0.148 mmol, 1 eq) in toluene (2 mL). 
The reaction was stirred overnight at reflux and, after completion, diluted EtOAc and washed 
with H2SO4 1 N, NaHCO3 sat. sol. and brine, dried over Na2SO4 and concentrated in vacuo. 
Purification of the crude was reached by column chromatography on silica gel (pe/EtOAc 8:2) 
affording 15 (70.4 mg, 0.091 mmol, 63 %) as yellow amorphous powder. TLC (petroleum 
ether/ethyl acetate 9:1): Rf= 0.57. 1H NMR (300 MHz, CDCl3) δ 7.6 (s, 1H), 7.3-7.2 (m, 15 H), 
6.82 (dd, J = 15.0, 7.0, Hz, 1H), 5.7 (d, J = 4.0 Hz, 1H), 5.45 (d, J = 10.13 Hz, 1H), 4.5 (br s, 
1H), 4.11 (s, 2 H), 3.3 (m, 1 H), 3.25 (m, 1H), 2.7-2.3 (AB, J = 16.3 Hz, 2 H), 2.35 (m, 1 H), 
2.2 (m, 1 H), 1.90 (s, 3H), 1.85 (d, J = 7.0 Hz, 3 H), 1.75 (s, 3 H), 1.4 (m, 2 H), 1.1 (s, 3H), 
1.05 (s, 3H),1.0 (s, 3H) 0.95-0.7 (m, 7 H).13C NMR (75 MHz, CDCl3) δ 194.46, 172.03, 167.46, 
144.85, 144.40, 141.58, 138.92, 138.30, 128.92, 128.07, 127.77, 127.57, 126.4, 86.66, 79.36, 
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75.88, 74.7, 65.2, 64.71, 43.3, 41.19, 40.95, 40.6, 38.96, 26.86, 25.1, 23.38, 20.2, 18.33, 
16.36, 15.47, 11.8, 10.33. 
Synthesis of 12-tigloyl-13-(S)-2-methylbutyril phorbol (16): To a solution of 15 (70 mg, 
0.09 mmol, 1 eq) in MeOH (2 mL), an aqueous solution of HClO4 60 % (3.3 µL, 0.033 mmol, 
0.37 eq) was added at room temperature. After stirring overnight at room temperature, the 
reaction is quenched with sodium acetate to pH 7, dilute with EtOAc and washed with brine. 
The collected organic phases were dried over Na2SO4 and concentrated in vacuo. Purification 
of the crude was reached by column chromatography on silica gel (pe/EtOAc 4:6) affording 
16 (46.8 mg, 0.088 mmol, 98%) as pale-yellow amorphous powder. TLC (petroleum 
ether/ethyl acetate 6:4): Rf= 0.20. 1H NMR (400 MHz, Chloroform-d) δ 7.57 (d, J = 2.1 Hz, 
1H), 6.82 (qd, J = 7.0, 1.7 Hz, 1H), 5.87 (s, 1H), 5.72 – 5.67 (m, 1H), 5.45 (d, J = 10.2 Hz, 
1H), 5.00 (t, J = 1.9 Hz, 0H), 4.93 – 4.86 (m, 1H), 4.08 – 3.89 (m, 3H), 3.27 (d, J = 6.3 Hz, 
1H), 3.26 – 3.18 (m, 1H), 2.59 (d, J = 19.1 Hz, 2H), 2.48 (d, J = 19.0 Hz, 1H), 2.41 – 2.27 (m, 
1H), 2.17 (dq, J = 10.1, 6.5 Hz, 1H), 2.05 (s, 1H), 1.82 (s, 1H), 1.80 – 1.76 (m, 3H), 1.73 (d, J 
= 1.6 Hz, 2H), 1.28 (s, 3H), 1.26 – 1.22 (m, 2H), 1.20 (s, 3H), 1.12 (d, J = 7.1 Hz, 4H), 0.92 (t, 
J = 7.5 Hz, 3H), 0.87 (d, J = 6.5 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 209.43, 179.28, 167.70, 
161.15, 140.65, 137.56, 132.93, 129.42, 128.64, 78.54, 73.83, 68.12, 65.47, 56.20, 43.51, 
41.39, 39.12, 38.59, 36.72, 26.30, 26.18, 23.95, 17.15, 16.30, 14.59, 14.54, 12.37, 11.74, 
10.22. 
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Fig. 1.23 13C-NMR spectra of 16 
Fig. 1.22 1H-NMR spectra of 16 
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Synthesis of 12,13-diacetyl-20-trityl phorbol (17): To a solution of 13 (500 mg, 0.824 mmol, 
1 eq) in pyridine (5 mL), Acetic anhydride (392.9 µL, 4.12 mmol, 5 eq) and a catalytic amount 
of DMAP were added. After stirring overnight, the reaction is diluted with EtOAc and washed 
several times with H2SO4 1 N. The collected organic phases were dried over Na2SO4 and 
concentrated in vacuo. Purification of the crude was reached by column chromatography on 
silica gel (pe/EtOAc 8:2) affording 17 (307 mg, 0.5356 mmol, 65 %) as a white amorphous 
powder. TLC (petroleum ether/ethyl acetate 6:4): Rf= 0.76. 1H NMR (300 MHz, CDCl3) δ 7.6 
(s, 1 H), 7.4-7.35 (m, 6H), 7.3-7.1 (m, 9 H), 5.69 (d, J = 5.9 Hz, 1H), 5.37 (d, J = 10.3 Hz, 1H), 
3.54 (s, 2 H), 3.10 (m, 1H), 3.06 (m, 1H), 2.50-2.15 (AB, J = 19 Hz, 2H), 2.10 (s, 3H), 2.06 (s, 
3H), 1.77 (d, J = 1.5 Hz, 3H), 1.23 (s, 3H), 1.17 (s, 3H), 1.05 (d, J = 5.2 Hz, 1H),0.9 (d, J= 6.5 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 209.25, 173.68, 171.04, 161.07, 143.98, 138.19, 132.63, 
129.49, 128.69, 127.93, 127.92, 127.80, 127.25, 127.00, 86.89, 77.94, 73.83, 69.03, 65.64, 
60.42, 56.10, 42.92, 39.25, 39.02, 36.24, 25.71, 23.92, 21.11, 21.08, 21.06, 16.73, 14.38, 
14.21, 10.13.  
Synthesis of 12,13,20-triacetyl phorbol (18): To a solution of 2 (500 mg, 1.37 mmol, 1 eq) 
in pyridine (5 mL), Acetic anhydride (653 µL, 6.85 mmol, 5 eq) and a catalytic amount of 
DMAP were added. After stirring overnight, the reaction is diluted with EtOAc and washed 
several times with H2SO4 1 N. The collected organic phases were dried over Na2SO4 and 
concentrated in vacuo. Purification of the crude was reached by column chromatography on 
silica gel (pe/EtOAc 7:3) affording 18 (556.4 mg, 1.134 mmol, 82 %) as a white amorphous 
powder. TLC (petroleum ether/ethyl acetate 6:4): Rf= 0.76. 1H NMR (300 MHz, CDCl3) δ 7.6 
(s, 1 H), 5.7 (m, 1H), 5.25 (d, J = 10.3 Hz, 1H), 5.1 (m, 1 H), 4.46-4.43 (AB, J =13.0 Hz, 2 H), 
2.6-2.42 (AB, J = 19.0 Hz, 2H), 3.2 (m, 1 H), 2.2 (m, 1 H), 2.12 (s, 3H), 2.11 (s, 3H), 2.05 (s, 
3H), 1.8 (s, 3H), 1.25 (s, 3H), 1.23 (s, 3H), 0.9 (m, 3H),  0.8 (d, J = 5.2 Hz, 1H). 13C NMR (75 
MHz, CDCl3) δ 209.1, 174.2, 171.2, 171.4, 161.4, 136.0, 133.3, 132.9, 78.4, 77.2, 69.8, 66.0, 
73.9, 56.4, 43.3, 39.6, 39.1, 36.5, 26.1, 24.2, 21.2, 21.4, 17, 14.8, 10.3  
General procedure for 12,13-diacetyl-20-formyl phorbol (19): To a solution of SeO2 (0.5 
eq) in DCM, a solution of tert-butylhydroperoxide 70 % (2 eq) was added. After 30 minutes, a 
solution of 17 or 18 in DCM was added dropwise. After stirring overnight at room temperature, 
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the reaction was diluted with DCM and washed with brine. The collected organic phases were 
dried over Na2SO4 and concentrated in vacuo. Purification of the crude was reached by 
column chromatography on silica gel (pe/EtOAc 8:2) affording 19 (35 % from 17, 19 % from 
18) as a pale yellow oil. TLC (petroleum ether/ethyl acetate 7:3): Rf= 0.29. 1H NMR (400 MHz, 
Chloroform-d) δ 9.45 (s, 1H), 7.58 (dd, J = 2.5, 1.4 Hz, 1H), 6.73 (dd, J = 5.8, 2.3 Hz, 1H), 
5.44 (d, J = 10.3 Hz, 1H), 3.64 (t, J = 5.6 Hz, 1H), 3.08 (q, J = 2.3, 1.8 Hz, 1H), 3.00 – 2.87 
(m, 1H), 2.49 (d, J = 19.7 Hz, 1H), 2.26 – 2.18 (m, 1H), 2.15 (s, 3H), 2.11 (s, 4H), 1.81 (dd, J 
= 2.9, 1.3 Hz, 4H), 1.28 (d, J = 4.6 Hz, 11H), 1.26 (dd, J = 2.9, 1.0 Hz, 2H), 0.93 (d, J = 6.5 
Hz, 3H), 0.89 (d, J = 9.8 Hz, 1H).13C NMR (101 MHz, CDCl3) δ 208.35, 208.32, 193.58, 
174.05, 171.06, 160.16, 156.79, 143.40, 133.65, 78.98, 77.48, 77.16, 76.84, 76.64, 72.83, 
65.43, 56.20, 43.26, 41.29, 35.78, 34.49, 32.08, 29.85, 29.51, 26.03, 23.87, 22.84, 21.22, 
21.14, 16.76, 14.56, 14.27, 10.24. 
Synthesis of 3β-hydroxy-12,13,20-triacetyl phorbol (20): To a solution of 18 (300 mg, 
0.611 mmol, 1 eq) in MeOH (3 mL), CeCl3*7H2O (227.6 mg, 0.611 mmol, 1 eq) and NaBH4 
(81 mg, 2.14 mmol, 3.5 eq) were added. After stirring for 7 minutes, the reaction was diluted 
with CHCl3 and washed with NH4Cl sat. sol and brine. The collected organic phases were 
dried over Na2SO4 and concentrated in vacuo. Purification of the crude was reached by 
column chromatography on silica gel (pe/EtOAc 8:2) affording 20 (225.3 mg, 0.457 mmol, 75 
%) as a colourless oil. TLC (petroleum ether/ethyl acetate 6:4): Rf= 0.40. 1H NMR (400 MHz, 
CDCl3) δ 5.71 (d, J = 1.9 Hz, 1H), 5.37 (d, J = 10.4 Hz, 1H), 4.58 (d, J = 1.1 Hz, 1H), 4.47 (q, 
J = 12.5 Hz, 2H), 4.12 (q, J = 7.1 Hz, 2H), 3.09 (s, 1H), 2.90 (t, J = 5.7 Hz, 1H), 2.82 – 2.73 
(m, 1H), 2.60 (d, J = 17.9 Hz, 1H), 2.17 (s, 0H), 2.09 (s, 2H), 2.08 (s, 2H), 2.07 (s, 2H), 2.04 
(s, 2H), 1.74 – 1.69 (m, 2H), 1.59 (s, 1H), 1.44 (s, 2H), 1.28 (s, 2H), 1.26 (s, 1H), 1.24 (s, 1H), 
1.23 (s, 2H), 1.21 (s, 3H), 1.02 (d, J = 4.8 Hz, 1H), 0.92 (d, J = 6.4 Hz, 2H). 13C NMR (101 
MHz, CDCl3) δ 173.54, 171.08, 170.84, 135.08, 133.68, 132.67, 129.80, 96.10, 88.59, 78.09, 
77.23, 68.94, 65.38, 60.42, 58.13, 43.05, 42.84, 39.93, 35.92, 29.44, 28.46, 25.44, 23.91, 
21.14, 21.04, 16.44, 14.25, 14.23, 13.48. 
Synthesis of 12,13,20-triacetyl phorbol-3,4-acetonide (21): To a solution of 20 (146.5 mg, 
0.2976 mmol, 1 eq) in a mixture of acetone and 2,2-dimethoxypropane (2:1 ratio, 1.5 mL:0.75 
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mL), pyridinium-p-toluene sulfonate was added. After stirring overnight at 50 °C, the reaction 
was diluted with CHCl3 and washed with brine. The collected organic phases were dried over 
Na2SO4 and concentrated in vacuo. Purification of the crude was reached by column 
chromatography on silica gel (pe/EtOAc 8:2) affording 21 (73 mg, 0.457 mmol, 46 %) as a 
yellow oil. TLC (petroleum ether/ethyl acetate 6:4): Rf= 0.72. 1H NMR (400 MHz, CDCl3)δ 5.76 
– 5.71 (m, 1H), 5.37 (d, J = 10.4 Hz, 2H), 4.62 (d, J = 1.4 Hz, 1H), 4.06 (d, J = 4.0 Hz, 2H), 
3.36 (dt, J = 3.4, 1.7 Hz, 1H), 3.26 (d, J = 8.9 Hz, 1H), 2.72 (d, J = 16.3 Hz, 1H), 2.09 (s, 5H), 
2.09 (s, 5H), 2.04 (s, 5H), 1.71 (dd, J = 2.8, 1.3 Hz, 5H), 1.44 (s, 1H), 1.37 (s, 4H), 1.27 (s, 
1H), 1.24 (s, 10H), 1.21 (s, 2H), 1.19 (s, 4H), 0.92 (d, J = 5.9 Hz, 2H), 0.88 (d, J = 6.4 Hz, 
5H).13C NMR (101 MHz, CDCl3) δ 173.54, 171.08, 170.84, 135.08, 133.68, 132.67, 129.80, 111.15, 
96.10, 88.59, 78.09, 77.23, 68.94, 65.38, 60.42, 58.13, 43.05, 42.84, 39.93, 35.92, 29.44, 28.46, 
25.44, 23.91, 21.14, 21.08, 21.04, 16.44, 14.25, 14.23, 13.48. 
Synthesis of 22a and 22b: To a solution of 21 (250 mg, 0.456 mmol, 1 eq) in Benzene (3 
mL), PCC (884.65 mg, 4.104 mmol, 9 eq) and sodium acetate (224.43 mg, 2.736 mmol, 6 eq) 
were added at room temperature. After stirring it for 1 h at 80 °C, the reaction was worked by 
by filtration on celite with toluene. The residue was dried under vacuo and purified by gravity 
column chromatography on silica gel (pe/EtOAc 8:2) affording 22a (45 mg, 0.08 mmol, 18 %) 
and (pe/EtOAc 7:3) 22b (125 mg, 0.216 mmol, 47%) both as colourless oil. TLC (petroleum 
ether/ethyl acetate 7:3): Rf(22a)= 0.43, Rf(22b)= 0.31. 
22a) 1H NMR (400 MHz, CDCl3) δ  6.74 (q, J= 1.5 Hz, 1H), 6.01 (d, J = 1.6 Hz, 1H), 5.78 (d, 
J = 10.2 Hz, 1 H), 4.80 (s, 1 H), 4.65 (s, 2 H), 3.32 (d, J = 9.85 Hz, 1 H), 2.98-2.51 (ABs, J = 
14.89 Hz, 2 H), 2.28 (s, 3 H), 2.09 (s, 3 H), 2.08 (s, 3 H), 1.81 (d, J = 1.26 Hz, 3 H), 1.43 (s, 3 
H), 1.26 (s, 3 H), 1.23 (s, 3 H), 0.87 (s, 3 H). 13C-NMR (101 MHz, CDCl3): δ 205.50, 195.19, 
175.17, 171.22, 170.79, 142.16, 132.86, 132.71, 129.78, 129.33, 114.04, 86.19, 84.25, 67.86, 
62.52, 42.65, 33.37, 30.55, 30.46, 28.61, 28.24, 22.07, 21.12, 21.10, 17.47, 16.19, 15.21. 
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Fig. 1.24 1H-NMR spectra of 22a 
Fig. 1.25 13C-NMR spectra of 22a 
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22b) 1H NMR (400 MHz, CDCl3) δ  13C-NMR (101 MHz, CDCl3): δ  5.67 (s, 1H), 5.37 (d, J = 
10 Hz, 1 H), 4.80 (s, 1 H), 4.32-4.23 (ABs, J = 11.60 Hz, 2 H), 3.02 (d, J = 5.30 Hz, 1 H), 2.66-
2.23 (ABs, J = 14.12 Hz, 2 H), 2.01 (s, 3 H), 2.00 (s, 3 H), 1.98 (s, 3 H), 1.77 (s, 3 H), 1.72 (d, 
J = 4.79, 1 H), 1.33 (s, 3 H), 1.16 (s, 3 H), 1.12 (s, 3 H), 0.82 (d, J = 6.31 Hz, 3 H). 13C-NMR 
(101 MHz, CDCl3): δ 202.28, 172.98, 171.18, 170.72, 143.28, 127.45, 113.44, 97.74, 95.53, 
94.83, 85.48, 81.15, 76.48, 65.40, 63.05, 48.41, 44.41, 41.68, 27.17, 27.11, 26.94, 23.51, 
21.27, 21.12, 21.03, 16.31, 14.53, 13.16. 
 
 
 
 
 
 
 
Fig. 1.26 1H-NMR spectra of 22b 
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Synthesis of 12,13-dihexanoyl- 5β-hydroxy-6,7α-epoxy phorbol-5,20-acetonide (23): To 
a solution of hexanoic acid (2.05 mL, 16.41 mmol, 5 eq) in DCM (15 mL), EDC (16.41 mmol, 
5 eq) and DMAP were added at room temperature. When EDC was completely dissolved, a 
solution of 12 (1.43 g, 3.28 mmol, 1 eq) in DCM (5 mL) was added dropwise. After stirring it 
overnight, the reaction was diluted with brine and extracted three times with DCM. The 
combined organic layers were dried over Na2SO4. After evaporation, the residue was purified 
by gravity column chromatography on silica gel (pe/EtOAc 8:2) affording 24 (1.65 g, 2.60 
mmol, 79 %) as white amorphous powder. TLC (petroleum ether/ethyl acetate 6:4): Rf= 
0.84.1H NMR (400 MHz, CDCl3) δ 7.56 (dd, J = 2.7, 1.5 Hz, 1H), 5.72 (s, 1H), 5.35 (d, J = 
10.0 Hz, 1H), 4.09 (s, 1H), 3.99 (t, J = 2.8 Hz, 1H), 3.92 (d, J = 12.9 Hz, 1H), 3.56 (d, J = 12.9 
Hz, 1H), 3.39 (s, 1H), 3.12 (d, J = 6.6 Hz, 1H), 2.96 (d, J = 1.1 Hz, 1H), 2.37 – 2.20 (m, 4H), 
1.87 (dq, J = 9.9, 6.4 Hz, 1H), 1.72 (dd, J = 2.9, 1.3 Hz, 3H), 1.59 (pd, J = 7.4, 3.8 Hz, 4H), 
1.46 (s, 3H), 1.43 (s, 3H), 1.32 – 1.24 (m, 8H), 1.22 (s, 3H), 1.20 (s, 3H), 0.86 (td, J = 6.9, 2.7 
Fig. 1.27 13C-NMR spectra of 22b 
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Hz, 6H), 0.80 (d, J = 6.5 Hz, 3H). 13C-NMR (101 MHz, CDCl3): δ 206.18 (Cq), 176.11 (Cq), 
173.51 (Cq), 161.47 (CH), 133.93 (Cq), 101.14 (Cq), 76.88 (Cq), 76.70 (CH), 72.70 (Cq), 68.56 
(CH), 65.71 (Cq), 65.65 (CH), 65.41 (CH2), 60.26 (Cq), 49.20 (CH), 45.46 (CH), 36.28 (CH), 
35.62 (CH), 34.55 (CH2), 34.27 (CH2), 31.23 (CH2), 31.21 (CH2), 26.37 (Cq), 24.94 (CH2), 
24.91 (CH2), 24.22 (CH3), 23.80 (CH3), 22.38 (CH2), 22.35 (CH2), 22.19 (CH3), 17.17 (CH3), 
15.02 (CH3), 14.01 (CH3), 13.93 (CH3), 10.03 (CH3). 
Synthesis of 12,13-dihexanoyl-5β-hydroxy-6α-hydroxy-7β-iodo phorbol-5,20-acetonide 
(24):  In a flamed round-bottomed flask iodine (176.39 mg, 1.39 mmol, 1 eq) was dissolved in 
dry DCM (2.5 mL) under nitrogen. After complete dissolution of iodine, triphenylphosphine 
(364.58 mg, 1.39 mmol, 1 eq) was added. The reaction colour turns from deep purple to 
yellow. After stirring at room temperature for 5 minutes, a solution of 23 (879 mg, 1.39 mmol, 
1 eq) in DCM (10 mL) was added. The reaction was stirred overnight at room temperature, 
turning from yellow-orange to colorless. After completion, it was quenched by MeOH, dilute 
with DCM and washed with a saturated aqueous solution of Na2S2O3 (x3) and brine (x1). The 
combined organic phases were dried over Na2SO4. Purification of the crude was reached by 
column chromatography on silica gel (pe/EtOAc 8:2) affording 24 (927.5 mg, 1.22 mmol, 88 
%) as white amorphous powder. TLC (petroleum ether/ethyl acetate 8:2): Rf= 0.5. TLC control 
(petroleum ether/ethyl acetate 8:2): Rf= 0.34.1H NMR (400 MHz, C2D6CO) δ 7.63 (dd, J = 2.4, 
1.4 Hz, 1H), 5.41 (s, 1H), 5.28 (d, J = 2.9 Hz, 1H), 5.25 (d, J = 10.6 Hz, 1H), 5.19 (d, J = 0.9 
Hz, 1H), 5.11 (d, J = 8.6 Hz, 1H), 4.48 (d, J = 8.3 Hz, 1H), 3.94 (d, J = 2.9 Hz, 1H), 3.76 (d, J 
= 8.3 Hz, 1H), 3.69 – 3.65 (m, 1H), 2.29 – 2.18 (m, 4H), 2.18 – 2.10 (m, 1H), 2.05 (dq, J = 
10.5, 6.5 Hz, 1H), 1.92 (p, J = 2.2 Hz, 3H), 1.68 (d, J = 5.9 Hz, 1H), 1.61 (dd, J = 2.8, 1.4 Hz, 
3H), 1.54 – 1.46 (m, 4H), 1.44 (s, 3H), 1.26 (s, 3H), 1.23 – 1.19 (m, 10H), 1.18 (s, 4H), 1.13 
(s, 3H), 0.77 (t, J = 7.4 Hz, 9H), 0.74 (d, J = 6.7 Hz, 4H).13C NMR (101 MHz, C2D6CO) δ 
208.24, 176.11, 173.02, 161.82, 133.22, 111.69, 88.98, 76.42, 75.68, 74.62, 73.79, 66.26, 
52.12, 46.67, 44.65, 44.34, 42.59, 33.96, 33.91, 30.97, 30.93, 27.49, 27.44, 26.09, 24.70, 
24.16, 22.33, 22.13, 22.10, 16.32, 14.25, 13.37, 13.31, 9.15. 
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Synthesis of 12,13-dihexanoyl-5β-hydroxy-6α-hydroxy-7β-iodo phorbol (25): To a 
solution of 24 (100 mg, 0.131 mmol, 1 eq) in ACN:H2O (2,5 mL), an aqueous solution of HClO4 
60 % (3 µL, 0.05 mmol, 0.37 eq) was added at room temperature. After 4 h a white precipitate 
is formed, the reaction is filtered on sintered glass funnel and the filtrate was washed with 
H2O, affording 25 (83.1 mg, 0.115 mmol, 88 %) as white amorphous powder. TLC (petroleum 
ether/ethyl acetate 6:4): Rf= 0.3. 1H NMR (400 MHz, CDCl3) δ 7.72 (s, 1H), 5.90 (s, 1H), 5.40 
(d, J = 9.0 Hz, 1H), 5.25 (d, J = 10.1 Hz, 1H), 4.45 (d, J = 11.1 Hz, 1H), 3.83 (s, 1H), 3.78 (d, 
J = 11.1 Hz, 1H), 3.13 – 3.07 (m, 1H), 2.26 (dtd, J = 13.2, 7.5, 2.7 Hz, 5H), 2.02 – 1.91 (m, 
2H), 1.80 (d, J = 6.2 Hz, 1H), 1.74 (t, J = 1.8 Hz, 3H), 1.56 (td, J = 7.4, 2.8 Hz, 4H), 1.25 (dt, 
J = 5.7, 1.9 Hz, 5H), 1.23 (s, 5H), 1.13 (s, 3H), 0.83 (td, J = 6.9, 2.5 Hz, 7H), 0.78 (d, J = 6.5 
Hz, 3H).13C NMR (101 MHz, CDCl3) δ 209.58, 176.75, 173.58, 164.18, 134.48, 79.67, 77.89, 
77.36, 76.18, 75.84, 73.63, 67.03, 66.70, 52.75, 52.34, 45.53, 45.04, 39.21, 34.59, 34.44, 
31.30, 31.28, 26.62, 24.98, 24.31, 22.78, 22.46, 22.42, 17.33, 15.15, 14.09, 14.03, 10.03. 
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2. Terpenes  
Terpenoids are the largest class of secondary metabolites isolated in living organisms. They 
take their name from the German word Terpentin (turpentine in English), from which they were 
first isolated, and thanks to the extensive efforts of Otto Wallach (Nobel prize, 1910) and 
Leopold Ruzicka (Nobel prize, 1989) we are now able to rationalize terpenes scaffolds under 
the flag of the Biogenetic Isoprene Rule. [1] After isolation of isoprene in 1961 by Sanadze 
and Dolidze as a decomposition product, the term hemiterpenes came into use to refer at the 
active biological precursors isopentenyl pyrophosphate (IPP) and its isomer 
dimethylallylpyrophosphate (DMAPP). [2] Condensation of the C-5 units commonly occur in a 
head-to-tail way, generating C-10 (monoterpenes), C-15 (sesquiterpenes), C-20 (diterpenes), 
C-25 (sesterpenes), C-30 (triterpenes), C-35 (sesquarterpenes), C-40 (tetraterpenes). By the 
way, in the last decade, several enzymes belonging to the class of prenyl diphosphate 
synthases rationalize complex pattern in higher terpenoids that cannot be explained following 
a simple head-to-tail condensation. These “irregular terpenoids” are quite rare in nature and 
often specific for certain genera or species and for this reason they can be used as chemo-
taxonomical marker to identify unknown species. Generation of the C-5 units in plants can be 
achieved through two different pathways: a cytosolic one known as mevalonate pathway (or 
HMG-CoA reductase pathway) common in eukaryotes, archaea and some bacteria and a 
plastidic pathway called mevalonate-independent pathway or 2-C-methyl-d-erythritol-4-
phosphate/1-deoxy-d-xylulose-5-phosphate pathway (MEP/DOXP). 
 
2.1 Mevalonic acid pathway 
 
Mevalonate pathway (MVA) represents a series of enzymatic reactions that occurs in fungi, 
plant cytoplasm, animals, most eukaryotes, archaea and some eubacteria to obtain 
isoprenoids from the activated acetyl-coenzyme A (1, Acetyl-CoA). The acetyl-coA thiolase 
(AACT) catalyses the extension of two units of acetyl-CoA through a Claisen condensation 
followed by a decarboxylative step to obtain acetoacetyl-coA (2). A third molecule of acetyl-
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coA reacts with the enzyme itself to enhance the aldol condensation with acetoacetyl-coA 
that, after hydrolysis by HMG-CoA synthase, release (S)-β-hydroxy-β-methylglutaryl 
coenzyme A (3, HMG-CoA). The sequential reductions of the thioester group by HMG-CoA 
reductase produces the aldehydic derivative (4) followed by the primary alcohol one (5), 
consuming two molecules of NADPH. The final product, (R)-(+)-mevalonic acid, is then 
pyrophosphorylated at C-5 hydroxy group by two ATP to produce mevalonic acid 5-
pyrophosphate (6, MVAA) in two steps. The further decarboxylative dehydration step 
catalysed by diphosphomevalonate decarboxylase is promoted by phosphorylation at the 
tertiary antiperiplanar hydroxy group to yield the final isopentenyl pyrophosphate (7, IPP). 
(Fig. 2.1)  
Isomerization of IPP is a process that requires IPP isomerase and water to catalyse the 
antarafacial 1,3-allylic rearrangement to produce γ,γ-dimethylallyl pyrophosphate (DMAPP). 
[Fig. 2.2] 
Fig. 2.1 Mevalonic acid pathway to IPP 
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2.2 Mevalonate-independent pathway: 2-C-methyl-D-erythritol-4-
phosphate (MEP)  
 
Toward the end of the 1980s, Rohmer and co-workers speculated a possible mevalonate-
independent pathway for isoprenoids biosynthesis after feeding experiment with labelled 
acetate, glucose, pyruvate and erythrose. Further investigations unearthed the occurrence of 
this pathway in bacteria and chloroplasts of green algae and higher plants. [4,5] 
Glyceraldehyde-3-phosphate (9) and pyruvic acid (10), intermediates mainly produced by 
glycolysis, are condensed by 1-deoxy-D-xylulose-5-phosphate synthase (DXS) to yield 1-
deoxy-D-xylulose-5-phosphate (11, DXP). In order to address the proper conversion of DXP 
by IspC reductoisomerase into 2-C-methyl-D-erythritol-4-phosphate (12), two different 
mechanisms were postulated: the first one is a retroaldol-aldol rearrangement that produces 
a molecule of glycolaldehyde phosphate and 1,2-dihydroxy-1-propene as intermediates, while 
the second one is α-ketol rearrangements. Both the pathways consume a molecule of 
NADPH. Compound 12 is cytidinylated by CTP through the activity of IspD, phosphorylated 
at the tertiary alcohol and cyclize to produce a 2,4-cyclodiphosphate with the elimination of 
CMP. IspG promotes the removal of the phosphates affording 1-hydroxy-2-methyl-2-(E)-
butenyl-4-diphosphate (13), which is later converted in IPP (7). (Fig. 2.3) 
Despite the notable importance of IPP isomerase to convert IPP to DMAPP, the production of 
the primary hemiterpenes can proceed independently via the resonance stabilized allylic 
carbocation of 13.  
Thanks to 13C-D-glucose experiments, it was possible to prove that the two distinct pathways 
have different cellular localization: mevalonate pathway occurs in cytoplasm and it is involved 
in the biosynthesis of sesquiterpenes, triterpenes and sterols, while DXP pathway takes place 
Fig. 2.2 Isomerization of IPP to DMAPP 
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in chloroplast (plastids) and it is focused on the biosynthesis of monoterpenes and diterpenes. 
[3] 
 
Even if the gene pool is separated inside the cell environment, IPP, DMAPP and other linear 
precursors of isoprenoids biosynthesis can be exchanged according to the “Cross-talk theory” 
and this could be an explanation of the late discovery of DXP pathway in feeding experiments. 
[6] 
2.3 Isoprenoid elongation: Diterpenes 
 
Isoprenoid polymerization proceeds through the activity of a class of enzyme called 
prenyltransferase which promotes the ionization of the allyl pyrophosphate group in DMAPP 
(7) by means of Mg2+ ion in the catalytic site. The electrophilic attack of IPP exomethylene C-
3,4 to the DMA+ carbocation occurs from the Re face (β) of the double bond with a final pro-
R proton elimination from the opposite face (α). Thus, the final product geranyl pyrophosphate 
(14) possess an E configuration at the newly formed double bond. (Fig. 2.4 a) The iteration 
of the process with four units of IPP (DMAPP) produces a molecule of (E,E,E)-geranylgeranyl 
pyrophosphate (GGPP, 19), the linear precursor in the biosynthesis of diterpenes. Particularly 
noteworthy is the fact that the reaction proceeds through a head-to-tail propagation where as 
Fig. 2.3 MEP pathway 
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the head is going to be considered the isopropylene group of DMAPP and as tail the carbon 
atom carrying the pyrophosphate group. [3] 
Most isoprenoids follow the head-to-tail propagation, however other polymerizations have 
been observed in nature from the reaction of IPP and DMAPP or their higher homologues. 
For example, lavandulol (15) and chrysantemic acid (16), two monoterpenoids that occur, 
respectively, in lavender essential oil and Chrysantemum cinerariaefolium (Trevir.) Vis extract, 
are produced from a head-to-middle condensation. [7,8] Anisotomenoic acid (17) and 
anisotomenol (18) (from Anisotome spp) are produced by coupling of two units of geranyl 
pyrophosphate in a head-to-head fashion. [9] 
Diterpenoid structural diversity arises from cascade reactions of the tetraprenyl precursor 19 catalyzed 
by a class of enzyme known as terpene cyclases. These enzymes can be broadly divided into two 
Fig. 2.4 Examples of propagation: a) head-to-tail to produce GPP b) head-to-middle for 
LPP and lavandulol c) head-to-middle in chrysanthemic acid d) head-to-head in 
anisotomenes 
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categories according to the chemistry that triggers the initial carbocation formation. Type I cyclases 
are metal-dependent enzymes that catalyze the formation of the allylic carbocation at C-1 by leaving 
of the terminal phosphate group. On the other side, class II cyclases induce the protonation at C-C 
double bond at the isopropylidene group producing a tertiary carbocation. The latter interacts with 
remaining π orbital to generate macrocyclic diterpenoid. [10]    
Euphorbiaceae family are excellent producers of macrocyclic and polycyclic diterpenoids with complex 
frameworks. As shown in Fig. 2.5, cyclization of GGPP (19) by class II terpenes cyclases produces 
abietanes (20), atisanes (21), pimaranes (22), kauranes (23), and trachylobanes (24) while the same 
process catalyzed by class I enzymes fall to, fo cembranes (25), casbanes (26) and jatrophanes (27).  
 
2.4 Topological biogenesis for tigliane diterpenoids  
 
Tigliane diterpenoids biosynthesis represents one of the most intriguing “black-box” in natural 
products chemistry. From a structural point of view, phorboids are polycyclic diterpenoids but, 
according to the previous described enzymatic reactions, the early stages aimed to rationalize 
the biosynthesis can be easily connected to a type I cyclization. By a topological standpoint, 
Fig. 2.5 Examples of cyclization promoted by terpene cyclase I (blue) and terpene cyclase II 
(red) 
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GGPP (19) cyclization mediated by the enzyme casbene synthase bring to casbene (27), a 
bicyclic diterpenoid [12.1.0] isolated from a cell-free extract of Ricinus communis exposed to 
fungi. Further ring closures between C-6 and C-10 (casbene numbering) foster the synthesis 
of the lathyrane skeleton (formerly lathyrene, 27). By lathyranes, it would be possible to 
achieve the jatrophane frame by the opening at the cyclopropane ring coming back to a 
bicyclic system. On the other side, closure at C-8 and C-14 (lathyrane numbering) represents 
the keystone to produce the tigliane skeleton (29). Breaking the cyclopropane ring might afford 
to rhamnopholanes (31) and daphnanes (32) while a ring expansion at ring C could rationalize 
the biosynthesis of ingenanes (30). (Fig. 2.6) 
Despite the easy way to interpret the carbon-carbon connectivity between phorboids, several 
mechanical issues lay a shadow on the derivation of tiglianes from lathyranes: 
1) Occurrence: Tigliane diterpenoids are well spread among Euphorbiaceae and 
Thymelaceae families while the isolation of lathyranes is ascribed up to now to few species of 
genera Euphorbia and Jatropha. If tiglianes should derive from lathyranes, the occurrence of 
the seconds' ones should be more marked. 
2) Hydroxylation at C-13: All natural tiglianes are characterized by a hydroxy group on the 
cyclopropane ring (C-13, tiglianes numbering) as well as ingenane while no lathyranes 
isolated so far contain this functionalization as shown in phorbol (2) and lathyrol (33). Carbon 
hydroxylation in a biological system is an iron radical-mediated process that would afford a 
cyclopropylalkyl radical instead of a cyclopropyl radical. The instability of the radical would, 
therefore, generate a 3-butenyl radical with, eventually, an opening of the cyclopropane ring. 
3) Functional group displacement: The closure keystone between C-8 and C-14 (lathyrane 
numbering) would require a previous functionalization at the lathyrane skeleton such as to 
rationalize the mechanism in term of nucleophilic/electrophilic properties. Again, lathyranes 
isolated so far contain generally a carbonyl group at C-14 and either a hydroxy group, 
electrophilic or a series of unfunctionalized methylenes. Moreover, most of them show an (E)-
double bond between C-12 and C-13 that, besides preventing spatial interaction between the 
substituents at C-8, C-14, should undergo to isomerization in tiglianes since (E)-double bond 
can exist in eight-membered or higher systems. [12] 
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Taken together, all of these observations reveal a kind of incompatibility between the direct 
biogenetic connection of lathyranes and tiglianes in flat models commonly shown in literature 
and textbook. 
  
Fig. 2.6 Topological biogenetic proposal for phorboids from lathyrane skeleton 
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2.5 Jasmin Jakupovic biogenetic proposal for phorboids 
 
An elegant proposal aimed to solve the riddle of the questionable relationship between 
tiglianes and lathyranes was proposed by prof. Jasmin Jakupovic (1949-2005) in the late 
2000s. Unfortunately, his premature demises foreclosed the spreading of his idea among the 
natural products chemistry community and this concept was relegated to laboratory meetings 
and a PhD thesis. [13]  
Starting from a retro-synthetical analysis, the opening of the cyclopropane ring could be done 
by direct protonation at C-13 or C-8, establishing a logical connection of the casbane skeleton 
to the cembrane one. If the newly generated cembranyl cation promotes the folding at C-13 
(tigliane numbering), the produced casbene would be incompatible in terms of cis 
stereochemistry at the formed cyclopropane and leave unsolved the hydroxylation at same 
Fig. 2.7 Retro-synthetical analysis of tigliane skeleton 
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one concurrently with the stereochemistry of the ring B double bond, E in the precursor and Z 
in tiglianes.  
To solve this incompatibility should be invoked an unusual closure by formal insertion of the 
side-chain cation center into a C(8)-H sigma bond that only after an oxidative rearrangement 
would result in the proper scaffold. This mechanism is associated with an inversion of the 
stereochemistry of double bond at C-2,3 (GGPP numbering) that can be explained by a classic 
isomerization of the canonical methylallyl phosphates of GGPP to an α-dimethylvinyl 
phosphates (geranyl-linalyl pyrophosphate, GLPP).  
So, the electrophilic attack proceeds on the si-face of the head of the tetraprenyl precursor by 
the vinyl group synclinal to the pyrophosphate to generate an opposite configuration of the 
double bond and the unusual localized cyclopropane ring. After cyclopentane ring A formation, 
possibly by an aldol-like condensation that promotes the isomerization of the double bond, 
the former lathyrane generated by the process has got the proper locations (∆5 and ∆12) 
shared by tiglianes, ingenanes and rhamnopholanes.  
The oxidative step aimed to introduce a ketone in α-position at the cyclopropane represents 
the keystone in Jakupovic proposal. Protonation at the carbonyl group triggers the formation 
of an unstable cyclopropylmethyl cation which is quenched by the endocyclic double bond 
and induces the transposition of the cyclopropane ring at C-13 to generate the controversial 
hydroxy ring D. A final quenching with water introduces the tertiary alcohol at C-9. All the other 
steps to achieve phorbol or EBC-46 can be rationalized as a series of oxidative steps and 
final acyl decoration with fatty acids, shorter or longer, linear or branched. [12] 
 
 
 75 
 
 
  
Fig. 2.8 Jakupovic proposal of tigliane skeleton biogenesis 
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2.6 Synthesis of labelled precursors to elucidate tigliane biogenetic 
pathway 
 
Labelling organic molecules with isotopes to highlight metabolic pathways provided since their 
first application in the first half of the XX century, new insights in biosynthesis research. With 
a concurrent rising of analytical techniques like NMR and MS, it was possible to switch from 
radioactive nuclei like 14C and 3H and their degradative analysis to 13C and 2H isotopes, more 
stable and easier to handle. Incorporation of labelled atoms in molecules understudy can 
provide important details to the stereochemical course of the biosynthetic pathway.[14]  
In order to determine whether Jakupovic proposal occurs in plants belonging to 
Euphorbiaceous family, a series of labelling experiments with 13C and 2H atoms are here taken 
in consideration. In fact, once the labelled atom is incorporated during the downstream 
process to synthesize the metabolite, the enrichment from the natural occurrence of carbon-
13 and deuterium (respectively, 1.1 % and 0.015%) can be easily detected by NMR 
spectroscopy by augmented intensity in the signals (relative abundance), coupling constants 
between the marked positions and, in 13C-NMR spectra, a slightly shift of the signals 
generated by labelled atoms towards lower fields.  
The synthesis of labelled GGPP (19) at position C-1 would eventually provide insight about 
the way how the cyclization takes place, as mentioned in Fig. 2.7, but it would not give any 
detail about the hydroxycyclopropane ring formation. Furthermore, geranylgeraniol is not 
efficiently taken up by plant cells. Thus, assuming that usually plant diterpenes are produced 
via the MEP pathway, a series of 1-deoxy-D-xylulose (11) isotopomers have been synthesized 
as a precursor for GGPP. Even if this carbohydrate can be used for MEP pathway as well as 
thiamine biosynthesis and pyridoxal phosphate [15], an increase of its concentration seems 
to enhance the activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR), key 
enzyme in the production of IPP/DMAPP [16] and feeding downstream intermediates, like 
MEP, do not produce any incorporation possibly to the missing phosphorylative machinery. 
[17] 
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The synthesis of isotopomers of 11 labelled at C-5 with 13C and 2H was performed starting 
from commercial propargyl alcohol which is protected with tert-butyldimethylsilyl chloride. 
Alkyne deprotonation proceeds with n-BuLi and insertion of the labelled substrate (p-
formaldehyde) followed by reduction to the corresponding allylic alcohol 35. Oxidation with 
PCC, compared to the previous attempt with Swern oxidation, reduces the loss of deuterium 
under 10 %. The enantioselective reduction with (R)- or (S)- alpine borane affords 37a-b, 
which enantiomeric excess was evaluated by esterification with the chiral α-methoxy-α-
trifluoromethylphenylacetic acid (Mosher’s ester). The newly generated allylic alcohol was 
protected by a benzyl group and treatment with TBAF provided the deprotection of the 
opposite silane. 39 was oxidized by IBX and, later, Grignard reaction with methylmagnesium 
bromide and its re-oxidation resulted in the methyl ketone. Thus, Sharpless dihydroxylation 
with AD-mix β and a catalytic hydrogenation with Pd/C afforded (5R)-(5-13C,5-2H)-1-deoxy-1-
D-xylulose (44a) and (5S)-(5-13C,5-2H)-1-deoxy-1-D-xylulose (44b). (Fig. 2.9) 
Synthesis of the remaining isotopomer of 11 was performed by esterification of fumaric acid 
(45) with trimethylsilyl chloride and subsequent reduction to the diol 47. Sever issues occurred 
during work-up of the reaction due to the high polarity of the diol and therefore its retention in 
water phase. Monoprotection with benzylbromide was achieved employing silver (I) chloride 
and the obtained product 48c follows the synthetical strategy developed for the synthesis of 
44a and 44b. 
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Fig. 2.9 Synthesis of (5R)- and (5S)-(5-13C,5-2H)-1-deoxy-1-D-xylulose (Respectively 44a 
and 44b). The enantioselective reduction was done with (S)-Alpine borane (i) for series 
“a” providing R = H; R1 = D while (R)-Alpine borane (ii) generated series “b” providing R 
= D; R1 = H 
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2.7 Labelling pattern from DXP incorporation in tigliane skeleton 
 
The labelling at the previously described DXP isotopomers have been strategically designed 
to evaluate in phase of biological incorporation crucial positions to prove or not the Jakupovic 
proposal. In fact, synthesis of di-labelled molecule 44a and 44b, during stochastic chain 
elongation, would produce isotopomers of GGPP (19) at least labelled once at C-1 position. 
The C-13/C-14 connection would proceed by the loss of the 1-pro-S proton of GPP to produce 
and E,E,E-casbene while, the C-8/C-14 connection, derived from a previous isomerization 
from GGPP to GLPP, would produce a Z,E,E-casbene because of the loss of 1-pro-R proton. 
The stereochemical course of the reaction can be evaluated by the occurrence or not at C-8 
(tigliane numbering) of deuterium. Due to intrinsic difficulties that can arise from evaluation of 
the occurrence of a single deuterium at GGPPs produced, an additional atom of 13C was 
Fig. 2.10 Synthesis of (2-13C, 5-13C)-1-deoxy-1-D-xylulose 
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added at the same position. Thus, it would therefore generate in the spectra of the 13C-NMR 
a singlet, if the C-8 does not contain extra deuterium, or a triplet if comes from coupling 
between the two isotopes. 
The isotopomer 44c, instead, was synthesized to establish if the formation of hydroxy-
cyclopropane is trigger by the insertion of carbonyl group in α at the cyclopropane as 
suggested by Jakupovic. If tigliane is synthesize in a topological manner a direct connection 
of carbon atom from different isoprene units would be detected by analysis of the coupling 
constant. Conversely, if the hydroxycyclopropane is formed after a rearrangement, the 
connection would arise from carbon atoms that come from the same DXP. (Fig. 2.11)   
Fig. 2.11 Possible pattern generated by feeding with labelled DXP 
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2.8 Supporting information 
 
Chemicals were purchased from Acros Organics (Geel, Belgium) or Sigma Aldrich Chemie 
(Steinheim, Germany) and used without any further purification. Solvents were purified by 
distillation and dried according to standard methods. All non-aqueous reactions were 
performed under an inert atmosphere (Ar) in flame-fired flasks. Thin-layer chromatography 
was performed with 0.2 mm precoated plastic sheets Polygram® Sil G/UV254 (Machery-
Nagel). Column chromatography was carried out using Merck silica gel 60 (70-200 mesh). 1H 
and 13C NMR spectra were recorded with Pollux Bruker AV III Prodigy (500 MHz) and Sirius 
Bruker AV III HD Cryo (700 MHz) spectrometers and referenced against solvent signals (1H-
NMR residual proton signals: CDCl3 δ=7.26, C6D6=7.16, D2O δ=4.79; 13C-NMR: CDCl3 
δ=77.16, C6D6=128.06). GC-MS analyses were recorded with HP 6890 gas chromatography 
connected to a HP 5973 inert mass detector fitted with a BPX-5 fused silica capillary column 
(25m, 0.25 mm i. d., 0.25 μm film). Instrumental parameters were (1) inlet pressure, 77.1 kPa, 
He 23.3 mL min-1, (2) injection volume, 2 μL, (3) transfer line, 300 °C, and (4) electron energy 
70 eV. The GC was programmed as follows: 5 min at 50 °C increasing at 10 °C min-1 to 320 
°C and operated in split mode (10:1, 60 s valve time). The carrier gas was he at 1 mL min-1. 
Retention indices (I) were determined from a homologous series of n-alkanes (C8-C38). Optical 
rotations were recorded with P8000 polarimeter (Krüss). 
Synthesis of tert-butyldimethylsilyloxy-1-propyne (33): tert-butyldimethylsilylchloride (32, 
50.72 g, 33.6 mmol, 1 eq) and imidazole (45.8 g, 67.2 mmol, 2 eq) were added to a solution 
of propargyl alcohol (1) (19.39 mL, 33.6 mmol, 1 eq) in dry DCM (600 mL) at 0 °C. After 1 h 
the mixture was quenched with H2O and extracted with DCM. The combined organic layers 
were dried over MgSO4 and concentrated in vacuo. Crude product was distillated under 
vacuum at 40 °C at 8 mmHg affording 2 (47.95 g, 28.15 mmol, 84%) as a colourless oil. TLC 
(cyclohexane/ethyl acetate 99:1): Rf= 0.2. GC (BPX-5): I= 983 .1H-NMR (500 MHz, CDCl3): δ 
= 4.31 (d, 4J(H,H) = 2.4 Hz, 2H, CH2), 2.39 (d, 4J(H,H) = 2.4 Hz, 1H, CH), 0.91 (s, 9H, 3 CH3), 
0.13 (s, 6H, 2 CH3) ppm. 13C-NMR (125 MHz, CDCl3): δ= 82.58 (Cq), 72.97 (CH), 51.66 (CH2), 
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25.94 (3 CH3), 18.43 (Cq), -5.06 (2 CH2) ppm. MS (EI, 70 eV): m/z (%) = 171 (<1) [M+], 146 
(16), 129 (8), 99 (2), 75 (100), 57 (2), 45 (3). [18] 
Synthesis of (1-13C, 1,1-2H2)-4-((tert-butyldimethyldilyl)oxy)but-2-yn-1-ol (34): To a 
solution of 2 (7.73 g, 45 mmol, 1.5 eq) in dry Et2O (165 mL), n-butyllithium (1.6 M in hexane, 
28.12 mL, 45 mmol, 1.5 eq) was slowly added at -78 °C and stirred for 1 h at -78 °C. [13C, 
2H2]-para-formaldehyde (1 g, 30 mmol, 1 eq) was added at -78 °C and the reaction mixture  
was stirred at room temperature overnight. The reaction was quenched with a saturated 
aqueous NH4Cl solution and extracted with diethyl ether. The combined organic layers were 
dried over MgSO4 and concentrated in vacuo. Purification of the crude was reached by column 
chromatography on silica gel (cyclohexane/ethyl acetate 8:2) affording 3 (5.49 g, 27 mmol, 
90%) as a colourless oil. TLC (cyclohexane/ethyl acetate 9:1): Rf= 0.22. GC (BPX-5): I= 1336 
.1H-NMR (500 MHz, CDCl3): δ = 4.35 (d, 4J(C,H) = 1.0 Hz, 2H, CH2), 0.91 (s, 9H, 3 CH3), 0.12 
(s, 6H, 2 CH3) ppm. 13C-NMR (125 MHz, CDCl3): δ= 84.68-84.47 (d, 1J(C,C) = 12.5 Hz, Cq), 
84.6 (d, 2J(C,C) = 1.6 Hz, Cq) , 51.8 (d, 3J(C,C) = 1.3 Hz, CH2), 50.8 (quint, 1J(13C,D) = 22.5 
Hz, 13CD2), 25.8 (3 CH3), 18.3 (Cq), -5.2 (2 CH2) ppm. MS (EI, 70 eV): m/z (%) = 203 (<1) 
[M+], 146 (5), 129 (3), 128 (27), 127 (18), 126 (3), 85 (4), 77 (9), 76 (18), 75 (100), 73 (6), 57 
(3), 45 (4), 39 (3). [19] 
Synthesis of (1-13C, 1,1-2H2)-4-((tert-butyldimethyldilyl)oxy)but-2-en-1-ol (35): To a 
solution of Red-Al® (17.36 mL, 53.38 mmol, 2 eq) in dry THF(135 mL) 3 (5.44 g, 26.75 mmol, 
1 eq) was slowly added  at -72 °C and let it warm up until 0 °C for 3 h. The reaction mixture 
was quenched with EtOAc (2 eq) and with an aqueous HCl solution 1 M (2 eq) at 0 °C. After 
10 minutes, the mixture was concentrated under pressure and dilute with 150 mL of ethyl 
acetate. The organic phase was extracted with a saturated aqueous NaHCO3 solution (x1) 
and washed with brine (x2). The combined organic layers were dried over MgSO4 and 
concentrated in vacuo affording 4 (5.19 g, 25.27 mmol, 94%) as a pale-yellow oil. TLC 
(cyclohexane/ethyl acetate 8:2): Rf= 0.28. GC (BPX-5): I= 1330 .1H-NMR (500 MHz, CDCl3): 
δ = 5.92-5.73 (br m, 2 H, 2 CH), 4.18 (br d, 2 H, CH2), 0.91 (s, 9H, 3 CH3), 0.13 (s, 6H, 2 CH3) 
ppm. 13C-NMR (125 MHz, CDCl3): δ= 131.34 (CH), 129.26-128.65 (d, 1J(C,C) = 46.3 Hz, CH), 
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63.29 (CH2), 62.65 (quint, 1J (13C,D2) = 22 Hz, 13C2D2), 25.7 (3 CH3), 18.34 (Cq), -5.37 (2 CH2) 
ppm. MS (EI, 70 eV): m/z (%) = 205 (<1) [M+], 148 (16), 130 (7), 129 (3), 77 (9), 76 (12), 75 
(100), 73 (7), 57 (4), 45 (2). Warning: 4-((tert-butyldimethyldilyl)oxy)but-2-en-1-ol is unstable 
on silica gel. Do not perform column chromatography on this compound. [20] 
Synthesis of (1-13C, 1,2H)-4-((tert-butyldimethyldilyl)oxy)but-2-en-1-al (36): To a solution 
of 4 (5.19 g, 25.27 mmol, 1 eq) in DCM (120 mL), PCC (8.17 g, 37.9 mmol, 1.5 eq) was added 
and the mixture was stirred at room temperature for 3h. The reaction was filtered on a silica 
pad with DCM and concentrated in vacuo. Purification of the crude was done by column 
chromatography on silica gel (petroleum ether/diethyl ether 8:2) affording 5 (3.6 g, 17.7 mmol, 
70%) as a colourless oil. TLC (cyclohexane/ethyl acetate 8:2): Rf= 0.22. GC (BPX-5): I= 1282. 
1H-NMR (500 MHz, CDCl3): δ = 6.88 (ddt, 3J(H,H) = 16 Hz, 3J(H,H) = 9 Hz, 3J(C,H) = 3 Hz, 
1H, CH), 6.39 (dtt, 3J(H,H) = 16 Hz, 3J(H,D) = 1.2 Hz, 2J(C,H) = 3 Hz, 1H, CH), 4.44 (quint, 
2H, CH2), 0.91 (s, 9H, 3 CH3), 0.08 (s, 6H, 2 CH3) ppm. 13C-NMR (125 MHz, CDCl3): δ = 193.4 
(quint 1J(13CD) = 22 Hz, Cq), 153.20-152.93 (d, 1J(C,C) = 46 Hz, CH), 130.5 (d, 2J(C,C) = 3 
Hz, CH), 63.2 (CH2), 25.8 (3 CH3), 18.3 (Cq), -5.2 (2 CH2) ppm. MS (EI, 70 eV): m/z (%) = 202 
(12) [M+], 146 (28), 145 (100), 131 (28), 127 (13), 115 (7), 113 (7), 101 (14), 100 (18), 99 (14), 
85 (6), 77 (25), 76 (93), 75 (100), 73 (30), 59 (15), 45 (7). [21] 
Synthesis of (1R)-(1-13C, 1-2H)-4-((tert-butyldimethyldilyl)oxy)but-2-en-1-ol (37a): A 
solution of 5 (1.8 g, 8.89 mmol, 1 eq) in 5 mL of Et2O was added dropwise to a solution of (S)-
Alpine borane® (0.5 M sol in THF, 21.34 mL, 10.67 mmol, 1.2 eq) in dry Et2O (40 mL) at room 
temperature and stirred for 4 h .The reaction was added of acetaldehyde (30 µL mmol-1) and 
stirred for 1 h, concentrated then under vacuum and diluted with diethyl ether (1.2 mL mmol-
1). After cooling the mixture at 0 °C, 2-aminoethanol (590.3 µL, 9.78 mmol, 1.1 eq) was added 
at the mixture and stirred for 1 h. The mixture was filtered with diethyl ether and extracted with 
water. The combined organic layers were dried over MgSO4 and concentrated in vacuo. 
Purification of the crude was reached by column chromatography on silica gel 
(cyclohexane/ethyl acetate 75:25) affording 6a (997 mg, 4.87 mmol, 55%) as a colourless oil. 
TLC (cyclohexane/ethyl acetate 9:1): Rf= 0.53. GC (BPX-5): I= 1300. 1H-NMR (500 MHz, 
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CDCl3): δ = 5.91-5.84 (br m, 1 H, CH), 5.82-5.77 (m, 1 H, CH), 4.27-3.99 (dm, 1J(13C,H) = 142 
Hz, 1H, 13CH), 4.18 (m, 2 H, CH2), 0.91 (s, 9H, 3 CH3), 0.08 (s, 6H, 2 CH3) ppm. 13C-NMR 
(125 MHz, CDCl3): δ= 131.25 (CH), 129.14-128.9 (d, 1J(C,C) = 46.3 Hz, CH), 63.20 (CH2), 
62.85 (quint, 1J (13C,D2) = 22 Hz, 13C2D2), 25.94 (3 CH3), 18.39 (Cq), -5.25 (2 CH2) ppm. MS 
(EI, 70 eV): m/z (%) = 204 (<1) [M+], 146 (28), 145 (100), 131 (28), 127 (13), 101 (14), 100 
(18), 99 (14), 77 (25), 76 (93), 75 (100), 73 (30), 59 (15), 45 (7). [22] 
Synthesis of (1S)-(1-13C, 1-2H)-4-((tert-butyldimethyldilyl)oxy)but-2-en-1-ol (37b): A 
solution of 5 (1.8 g, 8.89 mmol, 1 eq) in 5 mL of Et2O was added dropwise to a solution of (R)-
Alpine borane® (0.5 M sol in THF, 21.34 mL, 10.67 mmol, 1.2 eq) in dry Et2O (40 mL) at room 
temperature and stirred for 4 h .Acetaldehyde (30 µL mmol-1) was added at the reaction and 
stirred for 1 h, concentrated then under vacuum and diluted with diethyl ether (1.2 mL mmol-
1). After cooling the mixture at 0 °C, 2-aminoethanol (590.3 µL, 9.78 mmol, 1.1 eq) was added 
and let it stir for 1 h. The mixture was filtered with diethyl ether and extracted with water. The 
combined organic layers were dried over MgSO4 and concentrated in vacuo. Purification of 
the crude was reached by column chromatography on silica gel (cyclohexane/ethyl acetate 
75:25) affording 6b (1.22 g, 5.97 mmol, 67%) as a colourless oil. TLC (cyclohexane/ethyl 
acetate 9:1): Rf= 0.16. GC (BPX-5): I= 1300. 1H-NMR (500 MHz, CDCl3): δ = 5.91-5.84 (br m, 
1 H, CH), 5.82-5.77 (m, 1 H, CH), 4.27-3.99 (dm, 1J(13C,H) = 142 Hz, 1H, 13CH), 4.18 (m, 2 
H, CH2), 0.91 (s, 9H, 3 CH3), 0.08 (s, 6H, 2 CH3) ppm.13C-NMR (125 MHz, CDCl3): δ= 131.25 
(CH), 129.14-128.9 (d, 1J(C,C) = 46.3 Hz, CH), 63.20 (CH2), 62.85 (quint, 1J (13C,D2) = 22 Hz, 
13C2D2), 25.94 (3 CH3), 18.39 (Cq), -5.25 (2 CH2) ppm. MS (EI, 70 eV): m/z (%) = 204 (<1) 
[M+], 146 (28), 145 (100), 131 (28), 127 (13), 101 (14), 100 (18), 99 (14), 77 (25), 76 (93), 75 
(100), 73 (30), 59 (15), 45 (7). [22] 
 85 
 
 
Figure 2.. The enantiomeric excess was determined by 1H-NMR spectroscopy. Compounds 
37a-b (5 mg) were dissolved in dry DCM (380 µL). Dry pyridine (6 µL, 75.64 µmol, 3.1 eq) 
was added at room temperature and, after 30 min, (S)-(+)-α-methoxy-α-
(trifluoromethyl)phenylacetyl chloride (8.67 µL, 46.36 µmol, 1.9 eq) was added. The reaction 
mixture was stirred for 2 h, quenched with water and extracted with diethyl ether. The organic 
layers were dried over MgSO4 and concentrated in vacuo. The analysis of the products, after 
purification by column chromatography (petroleum ether/diethyl ether 98:2), reveals an ee of 
94.6% for 37a (upper signals) and 96.2% for 37b (lower signals). 
General Procedure for the Preparation of Isotopologues of (4-13C, 4-2H)-4-Benzyloxy-1-
((tert-butyldimethylsilyl)oxy)but-2-ene: To a solution of sodium hydride (60% suspension 
in mineral oil, 2.0 eq.) in dry THF (25 mL) 37a (1 eq, for 7a) or 37b (1 eq, for 7b) was added 
dropwise at 0 °C. Benzyl bromide (2.0 eq.) and dry DMF (2.0 eq) were added after 1h and the 
reaction mixture was stirred at room temperature overnight. The reaction was quenched with 
saturated aqueous NH4Cl solution and extracted with diethyl ether and water. The combined 
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organic layers were dried over MgSO4 and concentrated in vacuo. Column chromatography 
on silica gel (petroleum ether/diethyl ether 95:5) afforded 38a-b as a colourless oil. TLC 
(cyclohexane/ethyl acetate 9:1): Rf = 0.35. [23] 
(4R)-(4-13C, 4-2H)-4-Benzyloxy-1-((tert-butyldimethylsilyl)oxy)but-2-ene (38a): Yield (927 
mg, 3.14 mmol, 65%), GC (BPX-5): I = 1914. 1H-NMR (500 MHz, CDCl3): δ = 7.37-7.26 (m, 5 
H, 5 CH), 5.83 (m, 2 H, 2 CH), 4.52 (d, 3J(C,H) = 4 Hz, 2 H, CH2), 4.20 (m, 2H, CH2), 4.13-
3.91 (dm, 1J(CH)= 141 Hz, 1 H, 13CHD),  0.92 (s, 9H, 3 CH3), 0.08 (s, 6H, 2 CH3) ppm. 13C-
NMR (125 MHz, CDCl3): δ= 138.52 (d, 2J(C,C) = 2.9 Hz, CH), 132.83 (d, 3J(C,C) = 1.5 Hz, 
Cq), 128.51 (2 CH), 127.89 (2 CH), 127.70 (CH), 126.48-126.41 (d, 1J(C,C) = 48 Hz, CH), 
72.15 (d, 3J(C,C) = 1.5 Hz, CH2), 70.03 (t,1J(C,D) = 21.6 Hz, 13CD), 63.30 (d, 2J(C,C) = 6 Hz, 
CH2), 26.10 (3 CH3), 18.56 (Cq), -5.08 (2 CH2) ppm. MS (EI, 70 eV): m/z (%) = 294 (<1) [M+], 
237 (8), 165 (48), 135 (46), 131 (49), 101 (20), 91 (100), 75 (100), 73 (15).  
 (4S)-(4-13C, 4-2H)-4-Benzyloxy-1-((tert-butyldimethylsilyl)oxy)but-2-ene (38b): Yield 
(1.26 g, 4.28 mmol, 73%), GC (BPX-5): I = 1914. 1H-NMR (500 MHz, CDCl3): δ = 7.37-7.26 
(m, 5 H, 5 CH), 5.83 (m, 2 H, 2 CH), 4.52 (d, 3J(C,H) = 4 Hz, 2 H, CH2), 4.20 (m, 2H, CH2), 
4.13-3.91 (dm, 1J(CH)= 141 Hz, 1 H, 13CHD),  0.92 (s, 9H, 3 CH3), 0.08 (s, 6H, 2 CH3) ppm. 
13C-NMR (125 MHz, CDCl3): δ= 138.52 (d, 2J(C,C) = 2.9 Hz, CH), 132.83 (d, 3J(C,C) = 1.5 
Hz, Cq), 128.51 (2 CH), 127.89 (2 CH), 127.70 (CH), 126.48-126.41 (d, 1J(C,C) = 48 Hz, CH), 
72.15 (d, 3J(C,C) = 1.5 Hz, CH2), 70.03 (t,1J(C,D) = 21.6 Hz, 13CD), 63.30 (d, 2J(C,C) = 6 Hz, 
CH2), 25.97 (3 CH3), 18.47 (Cq), -5.09 (2 CH2) ppm. MS (EI, 70 eV): m/z (%) = 294 (<1) [M+], 
237 (9), 165 (53), 135 (51), 131 (54), 101 (24), 91 (100), 75 (13), 73 (15). 
General Procedure for the Preparation of Isotopologues of 4-Benzyloxybut-2-en-1-ol: 
To a solution of 38a or 38b (1.0 eq) in dry THF (20 mL) at 0 °C, TBAF (1.1 eq) was added 
dropwise under stirring. After 2h, the reaction mixture was 86ransformatio water and extracted 
with diethyl ether. The combined organic layers were dried over MgSO4 and concentrated in 
vacuo. Column chromatography on silica gel (cyclohexane/ethyl acetate 6:4) afforded 39a-b 
as a colourless oil. TLC (cyclohexane/ethyl acetate 7:3): Rf = 0.19 [23] 
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 (4R)-(4-13C, 4-2H)-4-Benzyloxybut-2-en-1-ol (39a): Yield (536 mg, 2.97 mmol, 96 %), GC 
(BPX-5): I = 1569. 1H-NMR (500 MHz, CDCl3): δ = 7.37-7.27 (m, 5 H, 5 CH), 5.95-5.89 (ddtd, 
3J(H,H) = 16 Hz, 3J(H,H) = 5.3 Hz, 3J(C,H) = 6 Hz, 4J(D,H) = 1.3 Hz, 1 H, CH), 5.87-5.82 (br 
dt, 3J(H,H) = 16 Hz, 3J(C,H) = 4.5 Hz, 1 H, CH), 4.53 (d, 3J(C,H)= 4 Hz, 2 H, CH2), 4.16 (dt, 
3J(H,H) = 5.3 Hz, 2J(H,H) = 1.3 Hz, 2 H, CH2), 4.13-3.90 (dm, 1J(CH)= 141 Hz, 1 H, 13CHD), 
1.65 (br s, 1 H, OH) ppm. 13C-NMR (125 MHz, CDCl3): δ= 138.32 (d, 2J(C,C) = 2.9 Hz, CH), 
132.4 (d, 3J(C,C) = 1 Hz, Cq), 128.53 (2 CH), 128.06 (2 CH), 127.88 (CH), 128.07-127.79 (d, 
1J(C,C) = 48 Hz, CH), 127.79 (CH), 72.4 (d, 2J(C,C) = 1.75 Hz, CH2), 69.85 (t,1J(C,D) = 21.8 
Hz, 13CD), 63.14 (d, 2J(C,C) = 6 Hz, CH2) ppm. MS (EI, 70 eV): m/z (%) = 180 (<1) [M+], 146 
(10), 131 (6), 107 (7), 105 (7), 92 (22), 91 (100), 79 (11), 77 (12), 65 (11), 51 (5).  
(4S)-(4-13C, 4-2H)-4-Benzyloxybut-2-en-1-ol (39b): Yield (711 mg, 3.94 mmol, 93 %), GC 
(BPX-5): I = 1570. 1H-NMR (500 MHz, CDCl3): δ = 7.37-7.27 (m, 5 H, 5 CH), 5.95-5.89 (ddtd, 
3J(H,H) = 16 Hz, 3J(H,H) = 5.3 Hz, 3J(C,H) = 6 Hz, 4J(D,H) = 1.3 Hz, 1 H, CH), 5.87-5.82 (br 
dt, 3J(H,H) = 16 Hz, 3J(C,H) = 4.5 Hz, 1 H, CH), 4.53 (d, 3J(C,H)= 4 Hz, 2 H, CH2), 4.16 (dt, 
3J(H,H) = 5.3 Hz, 2J(H,H) = 1.3 Hz, 2 H, CH2), 4.13-3.91 (dm, 1J(CH)= 141 Hz, 1 H, 13CHD), 
1.59 (br s, 1 H, OH) ppm. 13C-NMR (125 MHz, CDCl3): δ= 138.32 (d, 2J(C,C) = 2.9 Hz, CH), 
132.4 (d, 3J(C,C) = 1 Hz, Cq), 128.53 (2 CH), 128.06 (2 CH), 127.88 (CH), 128.07-127.79 (d, 
1J(C,C) = 48 Hz, CH), 127.79 (CH), 72.4 (d, 2J(C,C) = 1.75 Hz, CH2), 69.85 (t,1J(C,D) = 21.8 
Hz, 13CD), 63.14 (d, 2J(C,C) = 6 Hz, CH2) ppm. MS (EI, 70 eV): m/z (%) 180 (<1) [M+], 146 
(10), 131 (6), 107 (7), 105 (7), 92 (22), 91 (100), 79 (11), 77 (12), 65 (11), 51 (5).  
General Procedure for the Preparation of Isotopologues of 4-Benzyloxy-2-butenal: To a 
0.5 M solution of IBX (3.5 eq) in dry DMSO, 39a-c (1.0 eq) were added. The reaction mixture 
was stirred overnight at room temperature, filtered under vacuum on a sintered funnel covered 
by filter paper and diluted by water. The aqueous layer was extracted with ethyl acetate (3 x). 
The combined organic layers were dried over MgSO4 and concentrated in vacuo. Column 
chromatography on silica gel (petroleum ether/diethyl ether 75:25) afforded 40a-c as a 
colourless oils. TLC (cyclohexane/ethyl acetate 75:25): Rf = 0.36 [19] 
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(4R)-(4-13C, 4-2H)-4-Benzyloxy-2-butenal (40a): Yield (488 mg, 2.74 mmol, 92 %), GC (BPX-
5): I = 1530 . 1H-NMR (500 MHz, CDCl3): δ = 9.59 (d, 3J(H,H) = 8 Hz, 1 H, CHO), 7.39-7.29 
(m, 5 H, 5 CH), 6.87-6.82 (ddd, 3J(H,H) = 16 Hz, 2J(C,H) = 5.4 Hz, 3J(H,H) = 4.1 Hz, 1 H, CH), 
6.43-6.38 (dddd, 3J(H,H) = 16 Hz, 3J(H,H) = 8 Hz, 3J(C,H) = 5.4 Hz, 4J(H,H) = 2 Hz, 1 H, CH), 
4.59 (d, 3J(C,H)= 4.3 Hz, 2 H, CH2), 4.38-4.16 (dsest, 1J(13C,H)= 141 Hz, 1J(D,H)= 2.2 Hz, 1 
H, 13CHD) ppm. 13C-NMR (125 MHz, CDCl3): δ= 193.4 (d, 3J(C,C) = 7.3 Hz, Cq), 153.20-
152.93 (d, 1J(C,C) = 46 Hz, CH), 137.56 (d, 2J(C,C) = 3 Hz, CH), 132.05 (Cq), 128.67 (2 CH), 
128.11 (CH), 127.82 (2 CH), 73.1 (d, 2J(C,C) = 1.4 Hz, CH2), 68.35 (t,1J(C,D) = 21.8 Hz, 
13CHD) ppm. MS (EI, 70 eV): m/z (%) = 178 (<1) [M+], 146 (11), 131 (6), 107 (6), 105 (6), 92 
(19), 91 (100), 79 (11), 77 (12), 65 (11), 51 (4). 
(4S)-(4-13C, 4-2H)-4-Benzyloxy-2-butenal (40b): Yield (688 mg, 3.86 mmol, 96 %), GC (BPX-
5): I = 1530. 1H-NMR (500 MHz, CDCl3): δ = 9.59 (d, 3J(H,H) = 8 Hz, 1 H, CHO), 7.39-7.29 
(m, 5 H, 5 CH), 6.87-6.82 (ddd, 3J(H,H) = 16 Hz, 2J(C,H) = 5.4 Hz, 3J(H,H) = 4.1 Hz, 1 H, CH), 
6.43-6.38 (dddd, 3J(H,H) = 16 Hz, 3J(H,H) = 8 Hz, 3J(C,H) = 5.4 Hz, 4J(H,H) = 2 Hz, 1 H, CH), 
4.59 (d, 3J(C,H)= 4.3 Hz, 2 H, CH2), 4.38-4.16 (dsest, 1J(13C,H)= 141 Hz, 1J(D,H)= 2.2 Hz, 1 
H, 13CHD) ppm. 13C-NMR (125 MHz, CDCl3): δ= 193.4 (d, 3J(C,C) = 7.3 Hz, Cq), 153.20-
152.93 (d, 1J(C,C) = 46 Hz, CH), 137.56 (d, 2J(C,C) = 3 Hz, CH), 132.05 (Cq), 128.67 (2 CH), 
128.11 (CH), 127.82 (2 CH), 73.1 (d, 2J(C,C) = 1.4 Hz, CH2), 68.35 (t,1J(C,D) = 21.8 Hz, 
13CHD) ppm. MS (EI, 70 eV): m/z (%) = 178 (<1) [M+], 146 (11), 131 (6), 107 (6), 105 (6), 92 
(19), 91 (100), 79 (11), 77 (12), 65 (11), 51 (4). 
(1,4-13C2)-4-Benzyloxy-2-butenal (40c): Yield (355 mg, 1.99 mmol, 77 %), GC (BPX-5): I = 
1530. 1H-NMR (500 MHz, CDCl3): δ = 9.59 (dd, 1J(C,H) = 172.4 Hz, 3J(H,H) = 8 Hz, 1 H, 
CHO), 7.40-7.29 (m, 5 H, 5 CH), 6.85 (dddt, 3J(H,H) = 16 Hz, 2J(C,H) = 9.3 Hz, 3J(H,H) = 5.4 
Hz, 3J(C,H) = 4.1 Hz, 1 H, CH), 6.47-6.39 (m, 1 H, CH), 4.60 (d, 3J(C,H)= 4.3 Hz, 2 H, CH2), 
4.43-4.15 (ddddd, 1J(13C,H)= 142 Hz, 4J(C,H)= 4.3 Hz, 4J(H,H)= 1.9 Hz, 2J(H,H)= 1.5 Hz, 1 H, 
13CHD) ppm. 13C-NMR (125 MHz, CDCl3): δ= 193.4 (d, 3J(C,C) = 7.4 Hz, Cq), 153.13 (dd, 
1J(C,C) = 46 Hz, , 2J(C,C) = 4.4 Hz CH), 137.55 (d, 2J(C,C) = 2.8 Hz, Cq), 132.19-131.75 
(1J(C,C) = 46 Hz, CH), 128.69 (2 CH), 128.12 (CH), 127.82 (2 CH), 73.2 (d, 2J(C,C) = 1.3 Hz, 
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CH2), 68.7 (d,1J(C,D) = 7.4 Hz, 13CHD) ppm. MS (EI, 70 eV): m/z (%) = 178 (<1) [M+], 135 (4), 
108 (15), 107 (14), 92 (37), 91 (100), 79 (11), 77 (10), 65 (8). 
General Procedure for the Preparation of Isotopologues of 5-Benzyloxy-3-penten-2-ol:  
A solution of MeMgI (3.0 eq) prepared from Mg (3.0 eq) and MeI (3.0 eq) in diethyl ether (1.0 
M) was added dropwise to a ice cooled solution (0.12 M) of 40a-c. The reaction mixture was 
stirred for 3 h at 0 °C and quenched with water. The aqueous layer was extracted with diethyl 
ether, dried over MgSO4 and concentrated in vacuo. Column 89ransformation on silica gel 
(petroleum ether/ethyl acetate 7:3) afforded 41a-c as colourless oils. TLC (cyclohexane/ethyl 
acetate 75:25) Rf=0.13 [19] 
(5R)-(5-13C, 5-2H)-5- Benzyloxy-3-penten-2-ol (41a): Yield (395 mg, 2.03 mmol, 74 %), GC 
(BPX-5): I = 1584. 1H-NMR (500 MHz, CDCl3): δ = 7.37-7.26 (m, 5 H, 5 CH), 5.85-5.75 (m, 2 
H, 2 CH), 4.52 (d, 2J(C,H)= 4.3 Hz, 2 H, CH2), 4.34 (m, 1H, CH), 4.15-4.34 (dm, 1J(C,C) = 142 
Hz, 1 H, 13CHD), 1.61 (br s, 1 H, OH), 1.28 (d, 4J(C,H) = 6.4 Hz, 3 H, CH3) ppm. 13C-NMR 
(125 MHz, CDCl3): δ= 138.35 (d, 2J(C,C) = 2.8 Hz, Cq), 137.32 (CH), 128.54 (2 CH), 127.9 
(CH), 127.77 (2 CH), 126.5-126.1 (1J(C,C) = 48 Hz, CH), 72.4 (d, 2J(C,C) = 1.2 Hz, CH2), 69.9 
(t,1J(C,D) = 21.7 Hz, 13CHD), 68.37 (3J(C,H) = 6 Hz, CH), 23.3 (CH3) ppm.  
MS (EI, 70 eV): m/z (%) = 194 (<1) [M+], 165 (47), 145 (5), 135 (46), 131 (47), 115 (4), 101 
(21), 91 (100), 75 (15), 73 (15), 65 (4).  
 (5S)-(5-13C, 5-2H)-5- Benzyloxy-3-penten-2-ol (41b): Yield (573 mg, 2.95 mmol, 76 %), GC 
(BPX-5): I = 1585. 1H-NMR (500 MHz, CDCl3): δ = 7.37-7.26 (m, 5 H, 5 CH), 5.85-5.74 (m, 2 
H, 2 CH), 4.52 (d, 2J(C,H)= 4.3 Hz, 2 H, CH2), 4.34 (m, 1H, CH), 4.15-4.34 (dm, 1J(C,C) = 142 
Hz, 1 H, 13CHD), 1.61 (br s, 1 H, OH), 1.28 (d, 4J(C,H) = 6.4 Hz, 3 H, CH3) ppm. 13C-NMR 
(125 MHz, CDCl3): δ= 138.35 (d, 2J(C,C) = 2.8 Hz, Cq), 137.32 (CH), 128.54 (2 CH), 127.9 
(CH), 127.77 (2 CH), 126.5-126.1 (1J(C,C) = 48 Hz, CH), 72.4 (d, 2J(C,C) = 1.2 Hz, CH2), 69.9 
(t,1J(C,D) = 21.7 Hz, 13CHD), 68.37 (3J(C,H) = 6 Hz, CH), 23.3 (CH3) ppm. MS (EI, 70 eV): 
m/z (%) = 194 (<1) [M+], 165 (46), 145 (5), 135 (45), 131 (46), 115 (4), 101 (21), 91 (100), 75 
(15), 73 (15), 65 (5). 
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[2,5-13C2]-5- Benzyloxy-3-penten-2-ol (41c): Yield (235 mg, 1.21 mmol, 60 %), GC (BPX-5): 
I = 1584. 1H-NMR (500 MHz, CDCl3): δ = 7.36-7.26 (m, 5 H, 5 CH), 5.85-5.76 (m, 2 H, 2 CH), 
4.53 (d, 2J(C,H)= 4.3 Hz, 2 H, CH2), 4.46-4.21 (dm, 2J(C,H)= 142 Hz, 1H, CH), 4.13-3.91 (dm, 
2J(C,C) = 142 Hz, 1 H, 13CHD), 1.29 (dd, 1J(C,H) = 6.4 Hz,4J(C,H) = 4.4 Hz, 3 H, CH3) ppm. 
13C-NMR (125 MHz, CDCl3): δ= 137.38-137.09 (dd, 1J(C,C) = 47 Hz, 2J(C,C) = 1.4 Hz CH), 
130.80 (d,3J(C,C) = 3.5 Hz, Cq), 128.55 (2 CH), 127.9 (2 CH), 127.8 (CH), 126.58-126.28 
(1J(C,C) = 48 Hz, 2J(C,C) = 1.4 Hz , CH), 72.5 (d, 2J(C,C) = 1.5 Hz, CH2), 70.27 ( d, 1J(C,H)= 
6 Hz, 13CH), 68.41 (d,1J(C,H) = 6 Hz, 13CH), 23.3 (d, 1J(C,C)= 39 Hz,CH3) ppm. MS (EI, 70 
eV): m/z (%) = 178 (<1) [M+], 161 (4), 108 (27), 107 (19), 92 (34), 91 (100), 79 (10), 77 (6), 65 
(8), 44 (7). 
General Procedure for the Preparation of Isotopologues of 5-Benzyloxy-3-penten-2-
one:  
To a 0.5 M solution of IBX (3.5 eq) in dry DMSO were added 41a-c (1.0 eq). The reaction 
mixture was stirred overnight at room temperature, filtered under vacuum on a sintered funnel 
covered by paper and diluted by water. The aqueous layer was extracted with ethyl acetate 
(3 x). The combined organic layers were dried over MgSO4 and concentrated in vacuo. 
Column chromatography on silica gel (cyclohexane/ethyl acetate 85:15) afforded 42a-c as 
colourless oils. TLC (cyclohexane/ethyl acetate 75:25): Rf = 0.37 [19] 
(5R)-(5-13C, 5-2H)-5- Benzyloxy-3-penten-2-one (42a): Yield (320 mg, 1.66 mmol, 84 %), 
GC (BPX-5): I = 1617. 1H-NMR (500 MHz, CDCl3): δ = 7.39-7.28 (m, 5 H, 5 CH), 6.83-6.77 
(dt, 3J(H,H) = 16 Hz, 2J(C,H) = 5.25 Hz, 3J(H,H) = 4.7,  1H, CH), 6.38-6.32 (ddd, 3J(H,H) = 16 
Hz, 3J(C,H) = 6 Hz, 4J(H,H) = 1.9 Hz, 1H, CH), 4.57 (d, 3J(C,H) = 4.25 Hz, 2 H, CH2), 4.35-
4.02 (ses., 2J(H,D) = 2.25 Hz, 1J(C,H) = 141.36 Hz, 1 H, 13CHD), 2.27 (s, 3 H, CH3) ppm. 13C-
NMR (125 MHz, CDCl3): δ = 198.35 (d, 3J(C,C)= 6.0 Hz, Cq), 143.0 (d, 1J(C,C)= 46.0 Hz, CH), 
137.74 (2J(C,C)= 2.8 Hz, CH), 130.6 (Cq), 128.64 (2 CH), 128.04 (CH), 127.84 (2 CH), 73.02 
(d, 2J(C,C)= 1.0 Hz, CH2), 68.59 (t, 1J(C,D)= 21.6 Hz, 13CHD), 27.42 (CH3) ppm. MS (EI, 70 
eV): m/z (%) = 192 (<1) [M+], 145 (5), 134 (7), 106 (7), 105 (8), 92 (19), 91 (100), 86 (10), 79 
(6), 77 (12), 65 (7), 51 (5), 43 (11). 
 91 
 
 (5S)-(5-13C, 5-2H)-5- Benzyloxy-3-penten-2-one (42b): Yield (528 mg, 2.75 mmol, 95 %), 
GC (BPX-5): I = 1614. 1H-NMR (500 MHz, CDCl3): δ = 7.39-7.28 (m, 5 H, 5 CH), 6.83-6.77 
(dt, 3J(H,H) = 16 Hz, 2J(C,H) = 5.25 Hz, 3J(H,H) = 4.7,  1H, CH), 6.38-6.32 (ddd, 3J(H,H) = 16 
Hz, 3J(C,H) = 6 Hz, 4J(H,H) = 1.9 Hz, 1H, CH), 4.57 (d, 3J(C,H) = 4.25 Hz, 2 H, CH2), 4.35-
4.02 (ses., 2J(H,D) = 2.25 Hz, 1J(C,H) = 141.36 Hz, 1 H, 13CHD), 2.27 (s, 3 H, CH3) ppm. 13C-
NMR (125 MHz, CDCl3): δ = 198.35 (d, 3J(C,C)= 6.0 Hz, Cq), 143.0 (d, 1J(C,C)= 46.0 Hz, CH), 
137.74 (d,2J(C,C)= 2.8 Hz, CH), 130.6 (Cq), 128.64 (2 CH), 128.04 (CH), 127.84 (2 CH), 73.02 
(d, 2J(C,C)= 1.0 Hz, CH2), 68.59 (t, 1J(C,D)= 21.6 Hz, 13CHD), 27.42 (CH3) ppm. MS (EI, 70 
eV): m/z (%) = 192 (<1) [M+], 145 (5), 134 (7), 106 (7), 105 (8), 92 (19), 91 (100), 86 (10), 79 
(6), 77 (12), 65 (7), 51 (5), 43 (11). 
(2,5-13C2)-5- Benzyloxy-3-penten-2-one (42c): Yield (165 mg, 0.86 mmol, 75 %), GC (BPX-
5): I = 1616. 1H-NMR (500 MHz, CDCl3): δ = 7.39-7.28 (m, 5 H, 5 CH), 6.85-6.76 (dddt, 3J(H,H) 
= 16 Hz, 2J(C,H) = 6.4 Hz, 3J(C,H) = 5.1, 3J(H,H) = 4.5, 1H, CH), 6.39-6.32 (dddt, 3J(H,H) = 
16 Hz, 2J(C,H) = 6.4 Hz, 3J(C,H) = 2.8, 4J(H,H) = 1.9, 1H, CH), 4.58 (d, 3J(C,H) = 4.2 Hz, 2 H, 
CH2), 4.36-4.05 (dddd, 1J(C,H) = 142 Hz, 3J(H,H) = 4.4 Hz, 4J(H,H) = 1.9 Hz, 2J(H,H) = 1.2 
Hz, 1 H, 13CH2), 2.27 (d,1J(C,H) = 1.2 Hz, 3 H, CH3) ppm. 13C-NMR (125 MHz, CDCl3): δ = 
198.36 (d, 1J(C,C)= 6.0 Hz, Cq), 143.3-142.9 (dd, 1J(C,C)= 46.0 Hz, 2J(C,C)= 1.8 Hz, CH), 
137.8 (d,2J(C,C)= 2.8 Hz, Cq), 130.7-130.26 (d, 1J(C,C) = 53 Hz, CH), 128.65 (2 CH), 128.04 
(CH), 127.83 (2 CH), 69.62 (d, 2J(C,C)= 2.0 Hz, CH2), 68.95 (d, 2J(C,C)= 6 Hz, 13CH2), 27.4 
(CH3) ppm. MS (EI, 70 eV): m/z (%) = 192 (<1) [M+], 189 (29), 149 (10), 148 (20), 147 (100), 
133 (5), 131 (4), 117 (4), 73 (12). 
General procedure for the preparation of isotopologues of (3S,4R)-5-(Benzyloxy)-3,4-
dihydroxypentan-2-one: To a 1:1 mixture of distilled water and tBuOH, AD-mix β (1.6 g mmol-
1), K2OsO4 ∙ 2H2O (0.1 eq), NaHCO3 (3.0 eq) and MeSO2NH2 (1.0 eq) were added and cooled 
down at 0 °C. After 30 min, compounds 42a-c dissolved in a small amount of toluene were 
added dropwise to give a final concentration of 0.8 M of ketone in the reaction mixture. The 
reaction was stirred overnight at 0 °C and then diluted with ethyl acetate. Na2S2O5 (8.0 eq) 
was added carefully in small portions and extracted with ethyl acetate (3x), dried over MgSO4 
 92 
 
and concentrated in vacuo. Column chromatography on silica gel (cyclohexane/ethyl acetate 
65:35) afforded 43a-c as colourless oils. TLC (cyclohexane/ethyl acetate 6:4): Rf = 0.25 [19] 
 (5-13C, 5-2H)-(3S,4R,5R)-5-(Benzyloxy)-3,4-dihydroxypentan-2-one (43a): Yield (337 mg, 
1.49 mmol, 93 %). [α]D20 = +35.7 (c 10.4 in CHCl3). GC (BPX-5, MSTFA): I = 1929. 1H-NMR 
(500 MHz, CDCl3): δ = 7.39-7.27 (m, 5H, 5 CH), 4.57 (d, 3J(C,H)= 4.0 Hz, 2 H, CH2), 4.24 (br 
s, 1H, CH), 4.21 (br s, 1H, CH), 3.76-3.48 (dd, 3J(H,D)= 4.6 Hz, 1J(C,H)= 141.3 Hz, 1 H, 13CH), 
2.28 (s, 3 H, CH3). 13C-NMR (125 MHz, CDCl3): δ = 208.2 (d, 3J(C,C)= 3.0 Hz, Cq), 137.75 (d, 
3J(C,C)= 2.5 Hz, Cq), 128.66 (2 CH), 128.10 (CH), 128.02 (2 CH), 77.28 (CH), 73.78 (d, 
2J(C,C)= 1.3 Hz, CH2), 70.8 (t, 1J(C,D)= 22.0 Hz, 13CH), 25.74 (CH3) ppm. MS (EI, 70 eV): 
m/z (%) = 226 (<1) [M+], 218 (34), 193 (4), 179 (4), 147 (5), 91 (100), 73 (25). 
(5-13C, 5-2H)-(3S,4R,5S)-5-(Benzyloxy)-3,4-dihydroxypentan-2-one (43b): Yield (536 mg, 
2.37 mmol, 88 %). [α]D20 = +32.9 (c 11.35 in CHCl3). GC (BPX-5, MSTFA): I = 1929. 1H-NMR 
(500 MHz, CDCl3): δ = 7.38-7.29 (m, 5H, 5 CH), 4.57 (d, 3J(C,H)= 4.0 Hz, 2 H, CH2), 4.24 (t, 
1H, CH), 4.20 (m, 1H, CH), 3.75-3.46 (dd, 1J(H,D)= 6.5 Hz, 1J(C,H)= 143.5 Hz, 1 H, 13CHD), 
2.28 (s, 3 H, CH3). 13C-NMR (125 MHz, CDCl3): δ = 208.2 (d, 3J(C,C)= 3.0 Hz, 13Cq), 137.75 
(d, 3J(C,C)= 2.5 Hz, Cq), 128.66 (2 CH), 128.10 (CH), 128.02 (2 CH), 77.28 (CH), 73.78 (d, 
2J(C,C)= 1.3 Hz, CH2), 70.8 (t, 1J(C,H)= 22.0 Hz, 13CH2), 25.76 (CH3) ppm. MS (EI, 70 eV): 
m/z (%) = 226 (<1) [M+], 218 (31), 193 (4), 179 (4), 147 (5), 92 (10), 91 (100), 73 (25). 
 (2,5-13C2)- (3S,4R)-5-(Benzyloxy)-3,4-dihydroxypentan-2-one (43c): Yield (95 mg, 0.42 
mmol, 54 %). [α]D20 = +35.1 (c 5.98 in CHCl3). GC (BPX-5, MSTFA): I = 1929. 1H-NMR (500 
MHz, CDCl3): δ = 7.39-7.28 (m, 5H, 5 CH), 4.58 (d, 3J(C,H)= 4.0 Hz, 2 H, CH2), 4.24 (m, 1H, 
CH), 4.20 (m, 1H, CH), 3.78 (dd, 1J(C,H)= 6.1 Hz, 2J(H,H)= 1 H, 13CH2), 3.52-3.46 (dd, 
1J(C,H)= 6.1 Hz, 4J(H,H)= 1.8 Hz, 1 H, 13CH2), 2.28 (d, 2J(C,H)= 6.1 Hz, 3 H, CH3). 13C-NMR 
(125 MHz, CDCl3): δ = 208.17 (d, 3J(C,C)= 3.1 Hz, 13Cq), 137.75 (d, 3J(C,C)= 2.5 Hz, Cq), 
128.67 (2 CH), 128.11 (CH), 128.02 (2 CH), 71.16 (d, 1J(CH) = 3.1 Hz, 13CH2), 73.81 (d, 
2J(C,C)= 1.6 Hz, CH), 70.9 (d, 2J(C,H)= 1.5 Hz, 13CH2), 25.69 (d, 1J(C,H)= 42.0 Hz, CH3) ppm. 
MS (EI, 70 eV): m/z (%) = 226 (<1) [M+], 224 (6), 220 (10), 219 (36), 204 (4), 193 (5), 179 (4), 
147 (14), 103 (4), 92 (9), 91 (100), 73 (26). 
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General Procedure for the Preparation of 1-deoxy-D-xylulose isotopologues: To a 0.2 M 
solution of compounds 43a-c in iPrOH and water (9:1) a catalitic amount of Pd/C on activated 
charcoal was added (5 wt.%, 0.1 eq). The reaction mixture was stirred in a high-pressure 
reactor (HR-100, Berghof, Eningen) under a hydrogen atmosphere (40 bar) at 40 °C until 
consumption of the starting material. The mixture was filtered through a short pad of celite 
with iPrOH yielding 13a-c as colourless oils. TLC (ethyl acetate): Rf = 0.14. Warning: 1-deoxy-
D-xylulose derivatives decompose during column chromatography. [19] 
(5R)-(5-13C, 5-2H)-1-deoxy-D-xylulose (44a): Yield (182 mg, 1.49 mmol, 96 %). [α]D20 = + 2.8 
(c 15.5a in MeOH). 1H-NMR (500 MHz, D2O): δ = 4.43 (t, 3J(H,H)= 2.0 Hz, 1 H, CH), 4.20 (dt, 
2J(C,H) = 5.7, 3J(H,H) = 5.2 Hz, 3J(H,H) = 2.0 Hz, 1H, CH), 3.86-3.57 (dd, 3J(H,H)= 5.2 Hz, 
1J(13C,H)= 141.3 Hz, 1 H, 13CHD), 2.31 (s, 3 H, CH3). 13C-NMR (125 MHz, D2O): δ = 213.2 (d, 
3J(C,C)= 3.0 Hz, Cq), 71.16 (t, 2J(C,C)= 23 Hz, CH), 69.2 (t, 1J(C,C)= 23 Hz, CH), 61.86 (t, 
1J(C,C)= 23 Hz, 13CHD), 25.70 (CH3) ppm. MS (ESI) m/z [M+Na]+calcd. 159.05, obsd. 
159.058 
(5S)-(5-13C, 5-2H)- 1-deoxy-D-xylulose (44b): Yield (303 mg, 2.37 mmol, 96 %). [α]D20 = + 
2.6 (c 13.86 in MeOH). 1H-NMR (500 MHz, D2O): δ = 4.43 (t, 3J(H,H)= 2.0 Hz, 1 H, CH), 4.20 
(dt, 2J(C,H) = 5.7 Hz, 3J(H,H) = 5.2 Hz, 3J(H,H) = 2.0 Hz, 1H, CH), 3.86-3.57 (dd, 3J(H,H)= 5.2 
Hz, 1J(13C,H)= 141.3 Hz, 1 H, 13CHD), 2.31 (s, 3 H, CH3). 13C-NMR (125 MHz, D2O): δ = 
213.03 (d, 3J(C,C)= 3.0 Hz, Cq), 71.10 (t, 2J(C,C)= 23 Hz, CH), 69.13 (t, 1J(C,C)= 23 Hz, CH), 
61.85 (t, 1J(C,C)= 23 Hz, 13CHD), 25.70 (CH3) ppm. MS (ESI) m/z [M+Na]+calcd. 159.05, 
obsd. 159.057 
(2,5-13C2)- 1-deoxy-D-xylulose (44c): Yield (54 mg, 0.42 mmol, 99 %). [α]D20 = + 2.8 (c 15.5a 
in MeOH). 1H-NMR (500 MHz, D2O): δ = 4.43 (dt, 3J(C,H)= 3.7 Hz ,3J(H,H)= 2.0 Hz, 1 H, CH), 
4.21 (dddd, 2J(C,H) = 7.4 Hz, 3J(H,H) = 5.6 Hz, 3J(C,H) = 3.9 Hz, 3J(H,H) = 1.9 Hz, 1H, CH), 
3.82-3.50 (dm, 1J(13C,H)= 141 Hz, 1 H, 13CH2), 2.30 (d, 2J(C,H) = 6 Hz, 3 H, CH3). 13C-NMR 
(125 MHz, D2O): δ = 213.01 (d, 1J(C,C)= 3.1 Hz, Cq), 70.46 (d, 1J(C,C)= 245.7 Hz, CH), 62.93 
(dd, 1J(C,C)= 21.2 Hz, 2J(C,C)= 2.3 Hz, CH), 62.8 (d, 1J(C,H)= 3.2 Hz, 13CH2), 25.70 (d, 
1J(C,C)= 41 Hz, CH3) ppm. MS (ESI) m/z [M+Na]+calcd. 159.05, obsd. 159.055 
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Synthesis of (1,4-13C2) dimethylfumarate (45): To a solution of [1,4-13C2] fumaric acid (15) 
in dry MeOH (40 mL), trimethylsilylchloride was added (2.17 mL, 16.94 mmol, 2 eq). The 
reaction mixture was stirred overnight at room temperature and then quenched with water. 
After concentration, the residue was extracted with diethyl ether and brine. The organic layers 
were dried over MgSO4 and concentrated in vacuo affording 15 (1.21 g, 8.28 mmol, 98%) a 
white powder. Caution: The compound is highly volatile. Do not concentrated with high 
vacuum. TLC (cyclohexane/ethyl acetate 8:2): Rf= 0.65.GC (BPX-5): I= 1024. 1H-NMR (500 
MHz, CDCl3): δ= 6.86 (t, 2J(C,H)= 4.7 Hz, 2 H, 2 CH), 3.81 (d, 3J(C,H)= 3.8 Hz, 6 H, 2 CH3) 
ppm. 13C-NMR (125 MHz, CDCl3): 165.5 (13Cq), 133.86-133.26 (d, 1J(C,C)= 75.4 Hz, 2 CH), 
52.48 (t, 2J(C,C)= 1.0 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 146 (2) [M+], 116 (20), 115 
(100), 86 (35), 60 (10). [24] 
Synthesis of (1,4-13C2)-I-but-2-en-1,4-diol (46): To a solution of [1,4-13C2] dimethylfumarate 
in dry THF (40 mL) at 0 °C, DIBAL-H (1.0 M sol in hexane, 33.02 mL, 5.5 eq) was added 
dropwise. After 3h, the reaction was quenched with ethyl acetate (5.5 eq) and aqueous 1.0 M 
solution of hydrochloric acid (5.5 eq). The reaction mixture was concentrated in vacuo and 
extracted several times with ethyl acetate. The organic layers were dried over MgSO4 and 
concentrated in vacuo affording 17 (622 mg, 6.90 mmol, 84%) as a pale-yellow oil. TLC (ethyl 
acetate): Rf= 0.24. GC (BPX-5, MSTFA): I=1475 . 1H-NMR (500 MHz, MeOD): δ= 5.83 (m, 2 
H, 2 CH), 4.22 (m, 2 H, CH2), 3.94 (m, 2 H, CH2) ppm. 13C-NMR (125 MHz, CDCl3): δ 167.2 
(d, J(C,C)= 6.9 Hz, CH), 131.3 (d, J(C,C)= 47.78 Hz, CH), 63.07 (s, 2 13CH2) ppm. [25] 
Synthesis of (1,4-13C2)-4-Benzyloxybut-2-en-1-ol (48): To a solution of 17 (591 mg, 6.56 
mmol, 1.0 eq) in dry DCM (33 mL), Ag2O (2.28 g, 9.84 mmol, 1.5 eq) was added under stirring 
at room temperature. After 30 min, Benzyl bromide (863.1 µL, 7.22 mmol, 1.1 eq) was added. 
The reaction mixture proceeds overnight at room temperature. The crude was filtered on silica 
pad and concentrated in vacuo. Column chromatography on silica gel (cyclohexane/ethyl 
acetate 6:4) afforded 8c (467 mg, 2.59 mmol, 39%) as a colourless oil. TLC 
(cyclohexane/ethyl acetate 7:3): Rf = 0.19. GC (BPX-5): I=1568. 1H-NMR (500 MHz, CDCl3): 
δ = 7.39-7.26 (m, 5 H, 5 CH), 5.97-5.81 (m, 2 H, 2 CH), 4.53 (d, 3J(C,H)= 4 Hz, 2 H, CH2), 
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4.32-4.01 (dddd, 1J(C,H) = 142 Hz, 3J(H,H) = 5.4 Hz, 4J(H,H) = 1.9 Hz, 2J(H,H) = 0.9 Hz, 2 H, 
13CH2), 4.20-3.89 (ddp, 1J(C,H) = 142 Hz, 3J(H,H) = 5.4 Hz, 2J(H,H) = 1.0 Hz, 2 H, 13CH2) 
ppm. 13C-NMR (125 MHz, CDCl3): δ= 138.34 (d, 3J(C,C) = 3 Hz, Cq), 132.48-132.10 (d, 1J(C,C) 
= 46 Hz, CH), 128.55 (2 CH), 128.24-127.85 (d, 1J(C,C) = 46 Hz, CH), 127.89 (2 CH), 127.79 
(CH), 70.2 (d, 1J(C,H) = 6.3 Hz, 13CH2), 63.19 (d,1J(C,H) = 6.3 Hz, 13CH2), 61.98 (dd, 2J(C,C) 
= 6.3 Hz, 5J(C,C) = 1.2 Hz, CH2) ppm. MS (EI, 70 eV): m/z (%) = 180 (<1) [M+], 151 (2.5), 135 
(5), 108 (16), 107 (14), 92 (39), 91 (100), 79 (10), 77 (9), 65 (8). [26] 
N.B.: Compound 17 was turned into 40c applying the same reaction sequence used for the 
95ransformation of 40a-b into 44a-b 
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3. Feeding experiments on Fontainea picrosperma C.T.White  
 
Feeding exogenous precursors in leaving organism represent since the first application in the 
first half of the XX century a challenge for chemists interested into elucidation of biosynthetic 
pathway. So far, different established protocols occur in literature providing insight into the 
administration of labelled compounds. Quite often, these protocols rely on leaves or roots cell 
cultures where physiological and growth conditions can be controlled very precisely. 
Unfortunately, an optimized method to produce a cell culture from F.picrosperma, the chosen 
candidate for investigating tiglianes production, was not established yet. Just recently, plant 
domestication was achieved in Queensland to enhance the production of the experimental 
drug, EBC-46. [1] 
Direct application of 14C-amino acids was successfully performed in several experiments to 
elucidate fatty acids or alkaloids biosynthesis but, even though the low rate of incorporation, 
the emitted radioactivity has been efficiently used in decomposition study to establish the 
relative pathway by retro-synthetical analysis. [2] 
In order to achieve preliminary data about the biosynthesis of tigliane skeleton in the 
Euphorbiaceuous candidate, Fontainea picrosperma C.T. White, a series of different 
approaches are presented concurrently with relative issued encountered.  
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3.1 Feeding experiment with 13CO2 
 
Exposing plant tissues to 13CO2 is reported to be an efficient method to study the biosynthesis 
of primary and secondary metabolites and can provide, as well, insight about the tissue 
localization of the pathway itself tracing CO2-fixation. Heintze and co-workers proved that CO2 
flow takes place more efficiently at the leaf base of seedlings because of active developing 
chloroplasts with incomplete thylakoid stacking compared to leaf tips, where the thylakoids 
showed a maximal synthetical photosynthetic activity. [3] 
Feeding experiments on diatoms pointed out how CO2-fixation is strictly associated with MEP 
pathway for isoprenoid by preferential incorporation of carbon dioxide into phytol, the acyclic 
isoprenoid side chain of chlorophyll. Conversely, feeding with acetate resulted in better 
incorporation in triterpenoids produced in cytosol, possibly by enzymes involved in fatty acid 
metabolism. [4] 
Fig. 3.1 First sequence of reactions aimed to fix carbon dioxide in chloroplasts. 
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Mono-fixation can be traced by the reaction of CO2 with ribulose-1,5-disphosphate and the 
downstream process can be followed in light of Calvin cycle. The production of 
glyceraldehyde-3-phosphate (G3P) represents the key to have access to the synthesis of DXP 
and later on IPP/DMAP. (Fig. 3.1) 
Moreover, the process is aimed to recycle the primary phosphorylated sugar that, 
subsequentially, can be used to fix another molecule of carbon dioxide. In an atmospheric 
environment saturated with 13CO2, the iterative incorporation would continue until achieving a 
steady-state condition. A second incorporation of labelled 13CO2 is shown in Fig. 3.2 where 
complexity arises in terms of labelled positions at the precursors. 
 
A summary of the labelled pattern is presented in Table 1 to provide a complete series of 
possibility at any repetition of the biological process. As previously discussed, phorbol esters 
Fig. 3.2 Second sequence of reactions in Calvin cycle increase complex labelling pattern in DXP 
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occur in Euphorbiaceae and Thymelaceae families as a mixture of di- or tri-esters. In the case 
of tigilanol tiglate (EBC-46), tiglic and α-methylbutyric acids represent the acyl decorations at 
C-12 and 13. Plants biosynthesize these compounds starting from L-isoleucine that, in turn, is 
produced by pyruvic acid and α-ketoglutarate. [5] Thus, eventual labelling should be evaluated 
for the substituents as well.  
Noteworthy is C4-fixation pathway operated by plants in response of low level of atmospheric 
CO2 aimed to increase its concentration in bundle sheath cells, eliminating oxygenase activity 
and hence photorespiration.[6]  
  
Table. 1 Possible patterns arising from 13CO2 fixation in C-3 cycle 
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3.1.1 Results and discussion 
 
Four specimens of Fontainea picrosperma were used by analogy with the experiment 
designed by Bromand and co-workers applying 13CO2 at regular interval to enhance the 
distribution of fixed carbon in the entire plants. [7] All the plants were exposed twice a week 
at an aliquot of 13CO2, produced by injection in a water sealed Perspex box of a solution of 
H2SO4 1 M inside a becher containing Na213CO3. Every 2/3 days, the box was opened to allow 
the sampling and plants remained outside the box for 24 h prior repetition of the exposure. 
(Fig. 3.3) 
Among the period of 30 days, leaves and roots were sampled and extracted with methanol 
and analysed by HRMS-QToF to establish the isotopic ratio of EBC-46, EBC-47 and EBC-83 
occurring in a significant amount in F. picrosperma. Any consideration of the change in weight 
of the extract cannot be done because of the variability of the collected sample.  
Fig. 3.4 EBC-46 (1), EBC-47 (2), EBC-83 (3) 
Fig. 3.3 13CO2 feeding experiment in Fontainea picrosperma 
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Analysis of the average values suggests that, aside from an initial increase of the isotopic 
ratio, the incorporation of labelled 13CO2 proceeds in a fluctuating way towards a maximum 
value reached more than 10 days after the last pulse. The ratio comes back to the initial values 
after few weeks (60 days from time 0). The relative isotopic ratio between leaves and roots 
are quite comparable, with generally higher values in leaves. According to the shown trends 
for EBC-46, EBC-47 and EBC-83 it is not possible to draw the tissue localization of tiglianes 
production univocally. Leaves are more exposed to the close environment created for the 
experiments, as proven by the higher value. Conversely, it is known the carbon dioxide can 
efficiently flow through the soil and exchange gas with the radical apparatus. 
Two possibilities are, in conclusion, designed to explain the obtained result. As first, 
biosynthesis occurs only in one tissue and thanks to phloem/xylem system is delocalized in 
other sites. Secondly, biosynthesis occurs in both tissues with higher expression in leaves 
where the biosynthetic machinery affords the primary production.  
 
Fig. 3.5 Average values for EBC-46 isotopic ratio in Fontainea picrosperma 
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Fig. 3.6 Average values for EBC-47 isotopic ratio in Fontainea picrosperma 
Fig. 3.7 Average values for EBC-83 isotopic ratio in Fontainea picrosperma 
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3.2 Feeding experiments with 1-D-13C-glucose and DXP isotopomers 
 
The use of exogenous glucose in feeding experiments is a well-established method to predict 
in light of glycolytic pathway, glycogenesis, and the pentose phosphate pathway labelled 
pattern for isoprenoid precursors (acetyl-coA and pyruvate for MVA pathway or DXP for MEP 
pathway). In fact, following the downstream glycolytic process it would result in acetyl-coA 
labelled at C-2 which in MVA pathway could potentially bring at three labelled positions in IPP. 
(Fig.3.8A) Conversely, by condensation of glycerldehyde-3-phosphate and pyruvic acid (PA) 
in MEP pathway, a different labelling can be predicted for IPP, that could incorporate 13C at 
C-1 and C-5. (Fig. 3.8B) [8] 
  
Fig. 3.8 (A) Labelling generated by MVA pathway (B) Labelling generated by MEP 
pathway. 
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3.2.1 Results and discussion 
 
During the investigation of the most suitable technique for direct feeding, we have considered 
germination of F.picrosperma seeds in agar medium under controlled temperature and 
humidity. For this purpose, two seeds were cracked and sterilized using sterile water, EtOH 
70 % and bleach 1 %. Seeds were, after drying on sterile paper, laid down on a dish with half-
strength Murashige-Skoog basal medium. Unfortunately, after 3 days, fungal contamination 
starts to spread from the seed coat and cover the entire medium. Seeds collection, re-
sterilizing process and inoculation on a new media did not prevent the spreading of the fungi. 
For this reason and because of the intrinsic difficulties with handling Fontainea seeds (ca. 2 
cm long), the protocol was discharged.  
A group of four specimens, 1 seedling and 3 cuttings at different stages, were used to evaluate 
the performances of hydroponic system, the technique adopted for growing plant without soil 
by a water-based mineral nutrient solution. Oxygenation of the water tank was achieved by 
the use of a fish tank air pump laid directly into the system. Although all the plants look vital 
and healthy after 15 days, issues regarding the volume of the solution (at least 1.5 L) in which 
the labelled starting precursors should have been dispersed, led to the decision to change the 
technique again. 
Fig. 3.8 Hydroponic experiment with Fontainea picrosperma 
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Plant injection is a dispensing mean developed to administrate drugs (against pest or other 
diseases) directly inside the trunk of big trees. The concentrated fluid is usually vehiculate 
through under pressure devices and require one or two visits, before completion.  
In order to try the feasibility of the method, to one shooting and one cutting with 2.5 cm of the 
root apparatus, a solution of D-glucose (0.2 mM) in ethanol 10 % aq. was injected inside the 
stem using an insulin syringe. Stems were scratched and manual pressure was applied to 
promote the uptake among the day, while an air-filled balloon was connected during the night 
to maintain constant the administration. After one week the injection came to the end and 48 
h more were left to foster the processing of the sugar. Vegetal materials were sampled and 
finely chopped, stored in silica bags for 48 h to afford a complete drying and extracted several 
times with methanol. The extract was partitioned to achieve a fraction enriched with phorbol 
esters and simplify as much as possible the crude extract. Partitioning occured by diluting the 
crude with a 90 % methanol solution and washing the polar phase with n-hexane. Pure 
methanol brought to the formation of an emulsion with the apolar solvent in which was slightly 
soluble; after several considerations, we’ve found that adding a modest percentage of water 
(10 %) prevents the mixing of the two phases. The apolar fraction was collected separately 
and analyze it as well, while the polar was diluted with water (ratio 1:1) and re-extracted with 
dichloromethane. The organic phases were dried and analyze it with UHPLC-QToF to detect 
the occurrence of EBC-46, EBC-47 and EBC83. 
Analysis of the lipophilic and polar fraction of the cutting revealed a complete lack of phorbol 
esters in the polar phase interestingly, ruling out the possibility to use cuttings as specimens 
in further experiments. (Fig. 3.9a and b) Seedling, otherwise, shown the presence of EBC-46 
in the polar fraction as expected and declaring that the newly germinated seeds contain the 
desired product. (Fig. 3.10a and b) 
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Fig. 3.9a Lipophilic fraction of F.picrosperma cutting 
Fig. 3.9b Polar fraction of F.picrosperma cutting 
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Fig. 3.10 Lipophilic fraction of F.picrosperma shooting 
Fig. 3.10b Polar fraction of F.picrosperma shooting 
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A batch of 20 plants 5-months old were injected among a period of 3 weeks (2 weeks for 
injection, 1 week for setting) with a solution 0.4 mM (36.2 mg in 0.5 mL) of commercially 
available D-1-13C-glucose under controlled temperature and humidity conditions. The 
injections were performed by stabbing the stem of the plant and applying manual pressure. 
Vegetal tissues oppose resistance at the administration but using a pump or applying extra 
pressure at the piston translate in leaking from the site or injection or damaging the stem itself. 
Thus, direct injections into the leaves mid-ribs was evaluated to promote the maximum 
distribution of products in all the different tissues. All the vegetal material was processed as 
described above in order to obtain an enriched fraction of phorbol esters. The vast plethora 
of phorbol esters were reduced to one singular molecular entity as described in Supporting 
Information 1.2.2.2. providing 8.5 mg of 5β-hydroxy-6,7α-epoxy phorbol 5,20-acetonide (SIG 
609). 
Due to limited time to perform the experiments and optimizing methods, the DXP isotopomers 
synthesize in paragraph 2.6 were delivered in three plants each in the same way of glucose 
experiment. 
 
The spectroscopical analysis of 5β-hydroxy-6,7α-epoxy phorbol 5,20-acetonide performed at 
the University of the Sunshine Coast (Sippy Downs,Australia) with a 400 MHz NMR and at 
the University of Queensland (Brisbane, Australia) with 900 MHz did not provide any insight 
in terms of labelled position at the final skeleton, showing a complete overlapping of the 
signals of the unlabeled material in 1H-spectra (Fig. 3.11.1) while weak satellites signals were 
detected in products obtained with labelling with D-1-13C-glucose and (2-13C,5-13C)-1-deoxy-
1-D-xylulose, whose spectra were accumulated longer compared to the others. (Fig. 3.11.2)  
Labelled DXP Mark Quantity 
(5R)-(5-13C,5-2H)-1-deoxy-1-D-xylulose SIG606A 3.1 mg 
(5R)-(5-13C,5-2H)-1-deoxy-1-D-xylulose SIG607A 3.4 mg 
(2-13C,5-13C)-1-deoxy-1-D-xylulose SIG608A 0.7 mg 
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Fig. 3.11.1 1H-NMRs of 5β-hydroxy-6,7α-epoxy phorbol 5,20-acetonide in MeOD-d4 
Fig. 3.11.2 Detailed 13C-NMR of SIG 609A and SIG608A in MeOD-d4 
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The low enrichment was detected by UHPLC analysis, by the way, analysis of the peak of the 
product and further MS-MS spectra did not afford a clear pattern of incorporation. By 
calculation of the isotopic mean between the sodium salt of 5β-hydroxy-6,7α-epoxy phorbol 
5,20-acetonide plus one and the sodium salt, an increase of less than 5 % was detected in 
SIG 609 while a mean of almost 2 % in other DXP isotopomers. Given the natural abundance 
of 13C in nature, the obtained result confirms the issue in the spectroscopic analysis. (Fig. 
3.12) 
 
 
 
Fig. 3.12.1 HPLC-MS spectra of SIG591A (unlabeled)  
Fig. 3.12.2 HPLC-MS spectra of SIG606A  
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Fig. 3.12.3 HPLC-MS spectra of SIG607A  
Fig. 3.12.4 HPLC-MS spectra of SIG608A  
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Interestingly, injection of glucose solution did not seem to interfere with the inner homeostasis 
of plants (Fig. 3.13) while all the experiments performed with labelled DXP produced necrosis 
of the tissues since 24 h from the first application. The evolution of the necrosis was followed 
day-by-day during the experiment fearing for the death of the specimens but newly 
differentiated leaves at the top and the growing axillary buds led us to the conclusion the 
plants were not under an irreversible condition. (Fig. 3.14) 
Fig. 3.12.5 HPLC-MS spectra of SIG609A  
Fig. 3.13 Feeding experiment with D-1-13C-glucose   
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In conclusion, the negligible incorporation of the prospected precursors in tigliane skeleton 
pointed a series of hypothesis about the production of these compounds. As first, 
compartmentation effects prevent the access of biosynthetic precursors to biological sites (in 
this case, plastids). The second hypothesis is related to the production of tigliane diterpenoids 
at the early stages. Due to the complete lack of diterpenoids in cutting sample analyzed, it 
has been suggested that plants activate the biosynthetic machinery only later in life (possibly 
after blossoming or fruiting) in order to selectively delocalize the vesicles containing these 
secondary metabolites in seeds to protect them by predators or dispersers. After germination, 
plant distribute these compounds across all the vegetal tissue to ensure protection by 
herbivores. As third, the established method was not correct for these purposes and no 
labelled molecule was actually absorbed by the plant; however, extensive tissue necrosis 
would not be so marked.  
  
Fig. 3.14 Example of feeding experiment with DXP   
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3.3 Supporting information 
 
Chemicals and organic solvents were purchased from Cambridge Isotope Laboratories, Inc. 
(Massachusetts, USA) and Merck (Germany) and used without any further purification. All the 
samples were analysed by UHPLC, ExionLC (SCIEX, Boston, MA, USA) using a column 
Halo® RP-Amide (4.6 x 150 mm, 2.7 µm). A SCIEX X500 QTOF System operating in positive 
ionisation mode was used to analyse the eluted compounds. Formic acid (0.01%) was added 
to both mobile phases, water (A) and acetonitrile (B). The gradient elution condition was as 
follow: 58% B (0-13.0 min), 58-95% B (13.0-13.5 min), 95% B (13.5-15 min), 95-45% B (15-
15.1 min), 45% B (15.10-18 min). Column oven temperature and autosampler temperature 
were set at 40 ˚C and 15 ˚C, respectively. Sample injection volume was 2.0 µL with a flow 
rate of 1.0 mL/min. The MS parameters were as follow: ion source temperature, 650 ˚C; ion 
spray voltage, 5500 V; curtain gas, 40 psi; ion source gas 1, 50 psi; ion source gas 2, 60 psi; 
declustering potential (DP), 100 V; collision energy, 10 V; collision energy spread, 0 v; mass 
range for MS scan, m/z 100-1000. MS/MS experiments began with the system default minum 
value, namely m/z 50-100; DP, 100; collision energy 35 V; collision energy spread, 15. 
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3.3.1 Feeding experiment with 13CO2 
3.3.1.1 Plant material and feeding experiment 
Specimens of F. picrosperma (5-7 years old, 43-70 cm height) were cultivated in the 
greenhouse of USC, Sippy Downs, Queensland, Australia. Feeding experiments were 
performed in a period of 30 days on 4 plants. All the plants were arranged in a Perspex box 
with a total volume of 90 L and kept under controlled humidity and temperature in a 
glasshouse. According to the last measurement of atmospheric CO2 (455 ppm, 08/03/19), all 
the specimens were treated with an extra equivalent of 13CO2 by applying 1 M aq. sol. to 
Na213CO3 (181.97 mg). Every pulsing lasted for 36 h and, after opening the Perspex box, 
plants were left for 24 h in a free environment. Leaves and roots were collected and dried 
separately on silica for at least 48 h, before extracting with MeOH at room temperature over-
night. After complete removal of the solvent under vacuo, leaves and roots extracts were re-
dissolvent in MeOH with a concentration, respectively, of 10 mg mL-1 and 4.2 mg mL-1.  
3.3.1.2 Clone 123  
EBC-46 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 3.3 0.320451 0.249001 0.7 0.315089 0.216405 
11-mar-19 37.1 0.342440 0.218931 2.2 0.325973 0.211861 
14-mar-19 34.3 0.310939 0.215290 4.7 0.325648 0.207307 
18-mar-19 47.9 0.321519 0.220108 5.6 0.310481 0.199837 
21-mar-19 35.3 0.331584 0.199099 4.5 0.292752 0.216195 
25-mar-19 57.5 0.347871 0.227146 10.4 0.314132 0.235566 
28-mar-19 46.7 0.357909 0.203626 3.5 0.303937 0.216780 
1-apr-19 45.9 0.340595 0.216416 12.9 0.320046 0.198581 
4-apr-19 62.5 0.360585 0.258004 6.1 0.326757 0.218994 
8-apr-19 29.7 0.388521 0.250349 10.5 0.299284 0.200506 
10-apr-19 37.6 0.373776 0.234011 13.5 0.324797 0.210392 
15-apr-19 12.2 0.381759 0.235607 6.6 0.304359 0.207582 
18-apr-19 25.8 0.375308 0.251025 8.4 0.323057 0.211149 
Table 1. Summary of the isotopic ratio in leaves and roots of EBC-46 in clone 123 among the 
days 
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EBC-47 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 3.30 0.330920 0.239489 0.70 0.318487 0.212206 
11-mar-19 37.10 0.283189 0.422041 2.20 0.328599 0.224023 
14-mar-19 34.30 0.333380 0.278687 4.70 0.326253 0.212897 
18-mar-19 47.90 0.330823 0.212081 5.60 0.303233 0.198045 
21-mar-19 35.30 0.324686 0.197888 4.50 0.326008 0.196037 
25-mar-19 57.50 0.333852 0.223354 10.40 0.328568 0.218379 
28-mar-19 46.70 0.322600 0.232836 3.50 0.299744 0.219363 
1-apr-19 45.9 0.316780 0.214181 12.9 0.293394 0.200744 
4-apr-19 62.5 0.352288 0.234824 6.1 0.320833 0.199789 
8-apr-19 29.7 0.364322 0.227218 10.5 0.305893 0.211451 
10-apr-19 37.6 0.351456 0.242813 13.5 0.317910 0.220990 
15-apr-19 12.2 0.382542 0.278613 6.6 0.311026 0.207477 
18-apr-19 25.8 0.364337 0.225526 8.4 0.308770 0.214526 
 
Table 2. Summary of the isotopic ratio in leaves and roots of EBC-47 in clone 123 
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Fig. 1. Graphical scheme related to isotopic ratio distribution of EBC-46 in leaves and 
roots among the established period 
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Fig. 2. Graphical scheme related to isotopic ratio distribution of EBC-47 in leaves and roots 
among the established period 
EBC-83 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 3.30 0.345697 0.231997 0.70 0.339295 0.252389 
11-mar-19 37.10 0.350170 0.315819 2.20 0.330901 0.225930 
14-mar-19 34.30 0.328205 0.351726 4.70 0.330612 0.205041 
18-mar-19 47.90 0.317843 0.352889 5.60 0.312593 0.226028 
21-mar-19 35.30 0.370180 0.416098 4.50 0.298166 0.232307 
25-mar-19 57.50 0.342211 0.223680 10.40 0.309621 0.232309 
28-mar-19 46.70 0.318726 0.238159 3.50 0.324922 0.233717 
1-apr-19 45.9 0.319768 0.219893 12.9 0.300576 0.219633 
4-apr-19 62.5 0.354538 0.242564 6.1 0.302379 0.210528 
8-apr-19 29.7 0.352858 0.224662 10.5 0.300365 0.209399 
10-apr-19 37.6 0.362491 0.227417 13.5 0.306821 0.210159 
15-apr-19 12.2 0.400904 0.264194 6.6 0.311427 0.211719 
18-apr-19 25.8 0.366814 0.236975 8.4 0.319675 0.193712 
 
Table 3. Summary of the isotopic ratio in leaves and roots of EBC-83 in clone 123 
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Fig. 3. Graphical scheme related to isotopic ratio distribution of EBC-83 in leaves and roots among 
the established period 
3.3.1.3 Clone 234 
EBC-46 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 4.3 0.320451 0.249001 1.2 0.315089 0.216405 
11-mar-19 51.9 0.315889 0.222192 6.4 0.327742 0.219431 
14-mar-19 49.1 0.316379 0.197403 5.8 0.335813 0.205336 
18-mar-19 56.9 0.314789 0.207172 10.5 0.324489 0.207730 
21-mar-19 125.3 0.316729 0.225565 5.5 0.309401 0.219097 
25-mar-19 55.3 0.335580 0.209750 13.5 0.337158 0.220784 
28-mar-19 75.4 0.352690 0.228117 18.1 0.331391 0.213570 
1-apr-19 146.3 0.313406 0.187916 14.9 0.320652 0.217249 
4-apr-19 43.6 0.335476 0.234620 14 0.310971 0.204902 
8-apr-19 49.2 0.311635 0.204889 21.1 0.328348 0.204249 
10-apr-19 36 0.318858 0.219139 11.5 0.313385 0.222415 
15-apr-19 18.8 0.385029 0.242721 10.2 0.311189 0.216570 
18-apr-19 17.5 0.387078 0.228981 16 0.310913 0.207212 
 
Table 4. Summary of the isotopic ratio in leaves and roots of EBC-46 in clone 234 
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Fig. 4. Graphical scheme related to isotopic ratio distribution of EBC-46 in leaves and roots 
among the established period 
EBC-47 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 4.3 0.330920 0.239489 1.2 0.318487 0.212206 
11-mar-19 51.9 0.350355 0.427246 6.4 0.314500 0.221440 
14-mar-19 49.1 0.348673 0.311236 5.8 0.316725 0.238504 
18-mar-19 56.9 0.307639 0.249206 10.5 0.318299 0.217887 
21-mar-19 125.3 0.340323 0.230539 5.5 0.307823 0.218202 
25-mar-19 55.3 0.331139 0.228063 13.5 0.344877 0.195427 
28-mar-19 75.4 0.330131 0.213896 18.1 0.324529 0.215703 
1-apr-19 146.3 0.340734 0.228421 14.9 0.312503 0.223259 
4-apr-19 43.6 0.328636 0.204615 14 0.323914 0.197295 
8-apr-19 49.2 0.329295 0.213121 21.1 0.321406 0.208438 
10-apr-19 36 0.319617 0.211018 11.5 0.314876 0.197125 
15-apr-19 18.8 0.379006 0.245023 10.2 0.313701 0.190474 
18-apr-19 17.5 0.369876 0.239879 16 0.295888 0.213960 
 
Table 5. Summary of the isotopic ratio in leaves and roots of EBC-47 in clone 234 
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Fig. 5. Graphical scheme related to isotopic ratio distribution of EBC-47 in leaves and roots 
among the established period 
EBC-83 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 4.3 0.345697 0.231997 1.2 0.339295 0.252389 
11-mar-19 51.9 0.416747 0.337734 6.4 0.308692 0.226049 
14-mar-19 49.1 0.390137 0.558026 5.8 0.318285 0.227930 
18-mar-19 56.9 0.331423 0.277685 10.5 0.328337 0.212412 
21-mar-19 125.3 0.391059 0.325338 5.5 0.317988 0.194929 
25-mar-19 55.3 0.351800 0.283425 13.5 0.328120 0.228109 
28-mar-19 75.4 0.357524 0.237116 18.1 0.330673 0.234315 
1-apr-19 146.3 0.331264 0.448675 14.9 0.307863 0.229897 
4-apr-19 43.6 0.327806 0.217774 14 0.309813 0.208660 
8-apr-19 49.2 0.405826 0.267421 21.1 0.312061 0.210917 
10-apr-19 36 0.300588 0.212280 11.5 0.320984 0.211009 
15-apr-19 18.8 0.411787 0.258464 10.2 0.309444 0.215736 
18-apr-19 17.5 0.389142 0.242736 16 0.316825 0.225008 
 
Table 6. Summary of the isotopic ratio in leaves and roots of EBC-83 in clone 234 
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Fig. 6. Graphical scheme related to isotopic ratio distribution of EBC-83 in leaves and roots among 
the established period 
3.3.1.4 Clone 591 
EBC-46 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 15.1 0.320451 0.249001 3.8 0.315089 0.216405 
11-mar-19 35.8 0.317348 0.194489 2.1 0.329729 0.219496 
14-mar-19 31.6 0.313335 0.223431 3.7 0.333511 0.205905 
18-mar-19 27.8 0.343412 0.243235 5.1 0.345570 0.230859 
21-mar-19 44.5 0.337389 0.226536 5.6 0.324695 0.227529 
25-mar-19 34.1 0.363900 0.220709 8.6 0.319861 0.240233 
28-mar-19 44.7 0.333188 0.234040 12.6 0.314049 0.223009 
1-apr-19 32.5 0.310465 0.236561 9.4 0.319660 0.222404 
4-apr-19 35.5 0.337838 0.211217 10.8 0.318662 0.212925 
8-apr-19 30.9 0.329260 0.209219 14.2 0.345427 0.226374 
10-apr-19 26.8 0.342144 0.237677 11.9 0.317437 0.207408 
15-apr-19 23.4 0.365923 0.247769 3.5 0.314049 0.194763 
18-apr-19 23.8 0.357170 0.236860 8.3 0.318316 0.217117 
 
Table 7. Summary of the isotopic ratio in leaves and roots of EBC-46 in clone 591 
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Fig. 7. Graphical scheme related to isotopic ratio distribution of EBC-46 in leaves and roots among 
the established period 
EBC-47 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 15.1 0.320451 0.249001 3.8 0.315089 0.216405 
11-mar-19 35.8 0.296871 0.244227 2.1 0.338507 0.215312 
14-mar-19 31.6 0.318345 0.228526 3.7 0.327353 0.212199 
18-mar-19 27.8 0.344329 0.226325 5.1 0.408811 0.391635 
21-mar-19 44.5 0.333464 0.219953 5.6 0.309324 0.269489 
25-mar-19 34.1 0.326623 0.215483 8.6 0.311741 0.215552 
28-mar-19 44.7 0.319783 0.211259 12.6 0.296233 0.220976 
1-apr-19 32.5 0.322004 0.209455 9.4 0.317665 0.203731 
4-apr-19 35.5 0.303806 0.312539 10.8 0.301881 0.235651 
8-apr-19 30.9 0.301978 0.220980 14.2 0.352408 0.200764 
10-apr-19 26.8 0.317915 0.213685 11.9 0.313955 0.197992 
15-apr-19 23.4 0.355071 0.221616 3.5 0.292728 0.215938 
18-apr-19 23.8 0.343237 0.243397 8.3 0.315868 0.210640 
 
Table 8. Summary of the isotopic ratio in leaves and roots of EBC-47 in clone 591 
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Fig. 8. Graphical scheme related to isotopic ratio distribution of EBC-47 in leaves and roots 
among the established period 
EBC-83 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 15.1 0.320451 0.249001 3.8 0.315089 0.216405 
11-mar-19 35.8 0.379004 0.501309 2.1 0.330847 0.220238 
14-mar-19 31.6 0.363694 0.272587 3.7 0.321922 0.211519 
18-mar-19 27.8 0.347546 0.225435 5.1 0.307153 0.211656 
21-mar-19 44.5 0.332879 0.233678 5.6 0.365096 0.582947 
25-mar-19 34.1 0.340783 0.226099 8.6 0.328648 0.207812 
28-mar-19 44.7 0.334489 0.225676 12.6 0.330995 0.197035 
1-apr-19 32.5 0.318296 0.223376 9.4 0.318975 0.218567 
4-apr-19 35.5 0.321551 0.213100 10.8 0.307737 0.230368 
8-apr-19 30.9 0.331951 0.206268 14.2 0.323272 0.234059 
10-apr-19 26.8 0.335751 0.220172 11.9 0.310519 0.215102 
15-apr-19 23.4 0.366164 0.241970 3.5 0.296614 0.213204 
18-apr-19 23.8 0.347188 0.234047 8.3 0.305804 0.217489 
 
Table 9. Summary of the isotopic ratio in leaves and roots of EBC-83 in clone 591 
-0,030000
0,020000
0,070000
0,120000
0,170000
0,220000
0,270000
0,320000
0,370000
0,420000
8-
m
ar
-1
9
10
-m
ar
-1
9
12
-m
ar
-1
9
14
-m
ar
-1
9
16
-m
ar
-1
9
18
-m
ar
-1
9
20
-m
ar
-1
9
22
-m
ar
-1
9
24
-m
ar
-1
9
26
-m
ar
-1
9
28
-m
ar
-1
9
30
-m
ar
-1
9
1-
ap
r-
19
3-
ap
r-
19
5-
ap
r-
19
7-
ap
r-
19
9-
ap
r-
19
11
-a
pr
-1
9
13
-a
pr
-1
9
15
-a
pr
-1
9
17
-a
pr
-1
9
Clone 591 - EBC 47
M+1/M Leaves M+1/M Roots M+2/M+1 Leaves M+2/M+1 Roots
 127 
 
 
Fig. 9. Graphical scheme related to isotopic ratio distribution of EBC-83 in leaves and roots 
among the established period 
3.3.1.5 Clone 593 
EBC-46 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 7.2 0.320451 0.249001 0.9 0.315089 0.216405 
11-mar-19 33 0.306714 0.225440 3.4 0.316414 0.220487 
14-mar-19 27.8 0.323241 0.203469 3.4 0.317020 0.207177 
18-mar-19 47.4 0.309805 0.212533 5.8 0.329882 0.238132 
21-mar-19 41.1 0.309158 0.227720 2.3 0.320438 0.223110 
25-mar-19 33 0.353869 0.216820 5.4 0.301863 0.228347 
28-mar-19 43.8 0.336519 0.216419 4.1 0.341631 0.196126 
1-apr-19 31.7 0.307288 0.200347 9.8 0.305384 0.217611 
4-apr-19 32.1 0.352773 0.223185 2.8 0.318349 0.229101 
8-apr-19 39.3 0.326524 0.226765 12.5 0.324026 0.218413 
10-apr-19 30.1 0.314588 0.202449 12.2 0.304722 0.225791 
15-apr-19 17.7 0.341458 0.232977 4.9 0.321555 0.223608 
18-apr-19 26.2 0.403993 0.253899 5.3 0.312022 0.219495 
 
Table 10. Summary of the isotopic ratio in leaves and roots of EBC-46 in clone 593 
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Fig. 10. Graphical scheme related to isotopic ratio distribution of EBC-46 in leaves and roots 
among the established period 
EBC-47 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 7.2 0.320451 0.249001 0.9 0.315089 0.216405 
11-mar-19 33 0.332322 0.293575 3.4 0.332198 0.219794 
14-mar-19 27.8 0.326776 0.213446 3.4 0.316226 0.454295 
18-mar-19 47.4 0.335804 0.221817 5.8 0.402525 0.298190 
21-mar-19 41.1 0.309508 0.216962 2.3 0.327009 0.234304 
25-mar-19 33 0.324059 0.213673 5.4 0.342257 0.215073 
28-mar-19 43.8 0.329526 0.243566 4.1 0.336629 0.292597 
1-apr-19 31.7 0.305882 0.206694 9.8 0.317442 0.206544 
4-apr-19 32.1 0.342892 0.228847 2.8 0.328156 0.222223 
8-apr-19 39.3 0.321211 0.209429 12.5 0.328468 0.207897 
10-apr-19 30.1 0.305889 0.224801 12.2 0.320527 0.203973 
15-apr-19 17.7 0.325915 0.219058 4.9 0.319560 0.214775 
18-apr-19 26.2 0.377371 0.249454 5.3 0.310715 0.211446 
 
Table 11. Summary of the isotopic ratio in leaves and roots of EBC-47 in clone 593 
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Fig. 11. Graphical scheme related to isotopic ratio distribution of EBC-46 in leaves and roots 
among the established period 
EBC-83 
  Leaves Roots 
Date Yield(mg) M+1/M M+2/M+1 Yield(mg) M+1/M M+2/M+1 
8-mar-19 7.2 0.320451 0.249001 0.9 0.315089 0.216405 
11-mar-19 33 0.381355 0.278943 3.4 0.325126 0.224195 
14-mar-19 27.8 0.352089 0.332968 3.4 0.316455 0.209334 
18-mar-19 47.4 0.364053 0.292279 5.8 0.364609 0.434709 
21-mar-19 41.1 0.305477 0.239666 2.3 0.377731 0.277108 
25-mar-19 33 0.327933 0.267329 5.4 0.391163 0.256521 
28-mar-19 43.8 0.323077 0.269365 4.1 0.304428 0.209229 
1-apr-19 31.7 0.321871 0.229057 9.8 0.306033 0.212468 
4-apr-19 32.1 0.363928 0.239297 2.8 0.339319 0.243207 
8-apr-19 39.3 0.305923 0.241541 12.5 0.314724 0.205176 
10-apr-19 30.1 0.314139 0.222694 12.2 0.333149 0.219946 
15-apr-19 17.7 0.334576 0.227444 4.9 0.300410 0.219901 
18-apr-19 26.2 0.411879 0.254365 5.3 0.314889 0.204007 
 
Table 12. Summary of the isotopic ratio in leaves and roots of EBC-83 in clone 593 
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Fig. 12. Graphical scheme related to isotopic ratio distribution of EBC-83 in leaves and roots 
among the established period 
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3.3.2 Feeding experiment with 1-D-13C-glucose and DXP isotopomers 
 
General method for plant injections: Specimens of F. picrosperma (5 months old, 15-17 
cm height) were cultivated in the greenhouse of USC, Sippy Downs, Queensland, Australia. 
Labelled precursors solution (0.4 mM in 10 % EtOH aq. sol) were fed twice via direct stem 
and leaves injections with insulin syringes in a period of 10 days under controlled temperature 
(20 °C). All the plants were let them rest for 7 days prior to sampling and drying in a silica bag 
for 48 h. Dried vegetal material was extracted twice with MeOH, filtered and dried before re-
dissolving in 90 % aq. sol of MeOH. The methanolic phase was extracted three times with n-
hexane, diluted with water (ratio 1:1) and re-extracted several times with dichloromethane. 
The collected organic phases were dried over Na2SO4 and concentrated in vacuo. Protection 
at C-5, C-20 with the acetonide and transesterification of the acyl moiety to get 5β-6,7α-
epoxyphorbol-5,20-acetonide have been done as described in paragraph 1.2.2.2 
Samples Plant extract DCM phase Acetonide Transesterification 
SIG591A 10 mL (oil) 60.1 mg 45 mg 10.7 mg 
SIG606A 1.686 g 129 mg 144.6 mg 3.1 mg 
SIG607A 2.177 g 152 mg 196.4 mg 3.4 mg 
SIG608A 1.205 g 53.3 mg 40.5 mg 0.7 mg 
SIG609A 3.040 g 181.4 mg 180 mg 8.5 mg 
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Final conclusions 
 
Many plants of the Euphorbiaceae family produce strongly irritant and toxic latexes and oils, 
whose active constituents are known as “phorboids”. Natural phorboids like tiglianes are 
esters of the parent polyol phorbol. The optimized method to recover phorbol and hydroxy-
epoxyphorbol, here reported, provides a way to have access at the base skeleton for 
investigation of its chemistry and medicinal application, disregarding by complicated total 
synthetical approach. The peculiar activity exerted by phorbol esters addressed these 
compounds as lead molecules in drug development. Accessing tigliane skeleton or 
functionalize it for SAR studies represent a challenge due to the undisciplined reactivity that 
in some cases produce serendipitous discovery in the chemistry of this class of compounds. 
A contribute to investigating the chemical space of phorbol esters has been discussed on the 
chance of setting the basis for further studies aimed at the modification of ring B, possibly 
involved in the biological selectivity exploited by the experimental drug EBC-46 vs TPA. 
Moreover, preliminary studies on tissue localization and stereochemical course of the 
biosynthetic pathway have been performed in light of the elegant hypothesis proposed by prof. 
Jasmin Jakupovic. The obtained results suggest a semi-equal distribution of hydroxy-
epoxyphorbol esters in leaves and roots, with a slight tendency towards leaves. A protocol for 
plant injection was established by the administration of labelled glucose and DXP.  
If the first carbohydrate does not seem to interfere with the normal homeostasis, the second 
one produces significant necrosis of the tissue. Incorporation of “heavy” atom is not significant 
in the final tigliane skeleton invoking the suspect the biosynthetic machinery is not expressed 
at the early stages of plant life and that the occurrence of tiglianes in sprouts and shootings 
arise from what was already stored in seeds.  
Future investigations of this project will pay attention to the role of roots in older specimens to 
determine the exact localization of the biosynthesis. Other feeding experiments on mature 
plants are going to be evaluated concomitantly with a transcriptomic analysis of F.picrosperma 
to establish the enzyme involved in the pathway.  
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